Gary Lopaschuk - Publications

Affiliations: 
University of Alberta, Edmonton, Alberta, Canada 
Area:
Biochemistry, Molecular Biology, Recreation, Public Health

315 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Pherwani S, Connolly D, Sun Q, Karwi QG, Carr M, Ho KL, Wagg CS, Zhang L, Levasseur J, Silver H, Dyck JRB, Lopaschuk GD. Ketones provide an extra source of fuel for the failing heart without impairing glucose oxidation. Metabolism: Clinical and Experimental. 154: 155818. PMID 38369056 DOI: 10.1016/j.metabol.2024.155818  0.512
2024 Sun Q, Güven B, Wagg CS, de Oliveira AA, Silver H, Zhang L, Chen B, Wei K, Ketema E, Karwi QG, Persad KL, Vu J, Wang F, Dyck JRB, Oudit GY, ... Lopaschuk GD, et al. Mitochondrial fatty acid oxidation is the major source of cardiac ATP production in heart failure with preserved ejection fraction. Cardiovascular Research. PMID 38193548 DOI: 10.1093/cvr/cvae006  0.465
2024 Cho S, Dadson K, Sung HK, Ayansola O, Mirzaesmaeili A, Noskovicova N, Zhao Y, Cheung K, Radisic M, Hinz B, Sater AAA, Hsu HH, Lopaschuk GD, Sweeney G. Cardioprotection by the adiponectin receptor agonist ALY688 in a preclinical mouse model of heart failure with reduced ejection fraction (HFrEF). Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie. 171: 116119. PMID 38181714 DOI: 10.1016/j.biopha.2023.116119  0.31
2024 Güven B, Sun Q, Wagg CS, Almeida de Oliveira A, Silver H, Persad KL, Onay-Besikci A, Vu J, Oudit GY, Lopaschuk GD. Obesity Is a Major Determinant of Impaired Cardiac Energy Metabolism in Heart Failure with Preserved Ejection Fraction. The Journal of Pharmacology and Experimental Therapeutics. 388: 145-155. PMID 37977817 DOI: 10.1124/jpet.123.001791  0.774
2023 Sun Q, Wagg CS, Güven B, Wei K, de Oliveira AA, Silver H, Zhang L, Vergara A, Chen B, Wong N, Wang F, Dyck JRB, Oudit GY, Lopaschuk GD. Stimulating cardiac glucose oxidation lessens the severity of heart failure in aged female mice. Basic Research in Cardiology. PMID 38148348 DOI: 10.1007/s00395-023-01020-2  0.543
2023 Lopaschuk GD, Karwi QG. Jump Starting the Heart: Ketone Esters Improve Cardiac Function in Patients With Cardiogenic Shock. Jacc. Heart Failure. 11: 1348-1350. PMID 37452807 DOI: 10.1016/j.jchf.2023.06.006  0.343
2023 Lopaschuk GD, Persad KL. Failure to Launch: Impaired Cardiac Mitochondrial Metabolic Development in Newborns With Single Ventricle Heart Failure. Jacc. Basic to Translational Science. 8: 280-282. PMID 37034282 DOI: 10.1016/j.jacbts.2023.01.017  0.366
2023 Gopal K, Karwi QG, Tabatabaei Dakhili SA, Wagg CS, Zhang L, Sun Q, Saed CT, Panidarapu S, Perfetti R, Ramasamy R, Ussher JR, Lopaschuk GD. Aldose reductase inhibition alleviates diabetic cardiomyopathy and is associated with a decrease in myocardial fatty acid oxidation. Cardiovascular Diabetology. 22: 73. PMID 36978133 DOI: 10.1186/s12933-023-01811-w  0.368
2022 Hall AR, Karwi QG, Kumar S, Dongworth R, Aksentijević D, Altamimi TR, Fridianto KT, Chinda K, Hernandez-Resendiz S, Mahmood MU, Michelakis E, Ramachandra CJ, Ching J, Vicencio JM, Shattock MJ, ... ... Lopaschuk G, et al. Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury through a sirtuin-3 mediated increase in fatty acid oxidation. Scientific Reports. 12: 20551. PMID 36446868 DOI: 10.1038/s41598-022-23847-w  0.774
2022 Persad KL, Lopaschuk GD. Energy Metabolism on Mitochondrial Maturation and Its Effects on Cardiomyocyte Cell Fate. Frontiers in Cell and Developmental Biology. 10: 886393. PMID 35865630 DOI: 10.3389/fcell.2022.886393  0.349
2022 Lopaschuk GD, Hess DA, Verma S. Ketones regulate endothelial homeostasis. Cell Metabolism. 34: 513-515. PMID 35385704 DOI: 10.1016/j.cmet.2022.03.008  0.309
2022 Karwi QG, Lopaschuk GD. Branched-Chain Amino Acid Metabolism in the Failing Heart. Cardiovascular Drugs and Therapy. PMID 35150384 DOI: 10.1007/s10557-022-07320-4  0.531
2022 Ho KL, Karwi QG, Connolly D, Pherwani S, Ketema EB, Ussher JR, Lopaschuk GD. Metabolic, structural and biochemical changes in diabetes and the development of heart failure. Diabetologia. 65: 411-423. PMID 34994805 DOI: 10.1007/s00125-021-05637-7  0.39
2021 Karwi QG, Sun Q, Lopaschuk GD. The Contribution of Cardiac Fatty Acid Oxidation to Diabetic Cardiomyopathy Severity. Cells. 10. PMID 34831481 DOI: 10.3390/cells10113259  0.444
2021 Uddin GM, Karwi QG, Pherwani S, Gopal K, Wagg CS, Biswas D, Atnasious M, Wu Y, Wu G, Zhang L, Ho KL, Pulinilkunnil T, Ussher JR, Lopaschuk GD. Deletion of BCATm increases insulin-stimulated glucose oxidation in the heart. Metabolism: Clinical and Experimental. 154871. PMID 34478752 DOI: 10.1016/j.metabol.2021.154871  0.452
2021 Ketema EB, Lopaschuk GD. Post-translational Acetylation Control of Cardiac Energy Metabolism. Frontiers in Cardiovascular Medicine. 8: 723996. PMID 34409084 DOI: 10.3389/fcvm.2021.723996  0.344
2021 Lopaschuk GD, Karwi QG, Tian R, Wende AR, Abel ED. Cardiac Energy Metabolism in Heart Failure. Circulation Research. 128: 1487-1513. PMID 33983836 DOI: 10.1161/CIRCRESAHA.121.318241  0.547
2021 Greenwell AA, Gopal K, Altamimi T, Saed CT, Wang F, Tabatabaei-Dakhili SA, Ho KL, Zhang L, Eaton F, Kruger JL, Al Batran R, Lopaschuk GD, Oudit GY, Ussher JR. Barth Syndrome-Related Cardiomyopathy is Associated with a Reduction in Myocardial Glucose Oxidation. American Journal of Physiology. Heart and Circulatory Physiology. PMID 33929899 DOI: 10.1152/ajpheart.00873.2020  0.537
2021 Cai Y, Liu H, Song E, Wang L, Xu J, He Y, Zhang D, Zhang L, Cheng KK, Jin L, Wu M, Liu S, Qi D, Zhang L, Lopaschuk GD, et al. Deficiency of telomere-associated repressor activator protein 1 precipitates cardiac aging in mice p53/PPARα signaling. Theranostics. 11: 4710-4727. PMID 33754023 DOI: 10.7150/thno.51739  0.37
2020 Karwi QG, Wagg CS, Altamimi TR, Uddin GM, Ho KL, Darwesh AM, Seubert JM, Lopaschuk GD. Insulin directly stimulates mitochondrial glucose oxidation in the heart. Cardiovascular Diabetology. 19: 207. PMID 33287820 DOI: 10.1186/s12933-020-01177-3  0.351
2020 Lopaschuk GD, Karwi QG, Ho KL, Pherwani S, Ketema EB. KETONE METABOLISM IN THE FAILING HEART. Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids. 158813. PMID 32920139 DOI: 10.1016/j.bbalip.2020.158813  0.521
2020 Groenendyk J, Wang Q, Wagg C, Lee D, Robinson A, Barr A, Light PE, Lopaschuk GD, Agellon LB, Michalak M. Selective enhancement of cardiomyocyte efficiency results in a pernicious heart condition. Plos One. 15: e0236457. PMID 32790682 DOI: 10.1371/Journal.Pone.0236457  0.459
2020 Lopaschuk GD, Verma S. Mechanisms of Cardiovascular Benefits of Sodium Glucose Co-Transporter 2 (SGLT2) Inhibitors: A State-of-the-Art Review. Jacc. Basic to Translational Science. 5: 632-644. PMID 32613148 DOI: 10.1016/j.jacbts.2020.02.004  0.395
2020 Karwi QG, Biswas D, Pulinilkunnil T, Lopaschuk GD. Myocardial Ketones Metabolism in Heart Failure: Karwi et al. Role of ketone in heart failure. Journal of Cardiac Failure. PMID 32442517 DOI: 10.1016/j.cardfail.2020.04.005  0.407
2020 Ho KL, Karwi QG, Wagg C, Zhang L, Vo K, Altamimi T, Uddin GM, Ussher JR, Lopaschuk GD. Ketones can become the major fuel source for the heart but do not increase cardiac efficiency. Cardiovascular Research. PMID 32402081 DOI: 10.1093/cvr/cvaa143  0.428
2020 Karwi Q, Uddin GM, Wagg CS, Lopaschuk GD. Abstract MP125: Branched-chain Keto Acids, Not Branched-chain Amino Acids, Impairs Cardiac Insulin Sensitivity by Disrupting Insulin Signaling in the Mitochondria Circulation Research. 127. DOI: 10.1161/res.127.suppl_1.mp125  0.453
2019 Wang W, Zhang L, Battiprolu PK, Fukushima A, Nguyen K, Milner K, Gupta A, Altamimi T, Byrne N, Mori J, Alrob OA, Wagg C, Fillmore N, Wang SH, Liu DM, ... ... Lopaschuk GD, et al. Malonyl CoA Decarboxylase Inhibition Improves Cardiac Function Post-Myocardial Infarction. Jacc. Basic to Translational Science. 4: 385-400. PMID 31312761 DOI: 10.1016/j.jacbts.2019.02.003  0.549
2019 Uddin GM, Zhang L, Shah S, Fukushima A, Wagg CS, Gopal K, Al Batran R, Pherwani S, Ho KL, Boisvenue J, Karwi QG, Altamimi T, Wishart DS, Dyck JRB, Ussher JR, ... ... Lopaschuk GD, et al. Impaired branched chain amino acid oxidation contributes to cardiac insulin resistance in heart failure. Cardiovascular Diabetology. 18: 86. PMID 31277657 DOI: 10.1186/s12933-019-0892-3  0.469
2019 Karwi QG, Jörg AR, Lopaschuk GD. Allosteric, transcriptional and post-translational control of mitochondrial energy metabolism. The Biochemical Journal. 476: 1695-1712. PMID 31217327 DOI: 10.1042/BCJ20180617  0.425
2019 Altamimi TR, Gao S, Karwi QG, Fukushima A, Rawat S, Wagg CS, Zhang L, Lopaschuk GD. Adropin Regulates Cardiac Energy Metabolism and Improves Cardiac Function and Efficiency. Metabolism: Clinical and Experimental. PMID 31202835 DOI: 10.1016/J.Metabol.2019.06.005  0.436
2019 Marzilli M, Vineareanu D, Lopaschuk G, Chen Y, Dalal JJ, Danchin N, Etriby E, Ferrari R, Gowdak LH, Lopatin Y, Milicic D, Parkhomenko A, Pinto F, Ponikowski P, Seferovic P, et al. Trimetazidine in cardiovascular medicine. International Journal of Cardiology. PMID 31178223 DOI: 10.1016/J.Ijcard.2019.05.063  0.556
2019 Karwi QG, Zhang L, Altamimi TR, Wagg CS, Patel V, Uddin GM, Joerg AR, Padwal RS, Johnstone DE, Sharma A, Oudit GY, Lopaschuk GD. Weight Loss Enhances Cardiac Energy Metabolism and Function in Heart Failure Associated with Obesity. Diabetes, Obesity & Metabolism. PMID 31050157 DOI: 10.1111/dom.13762  0.43
2019 Ho KL, Zhang L, Wagg C, Batran RA, Gopal K, Levasseur J, Leone T, Dyck JRB, Ussher JR, Muoio DM, Kelly DP, Lopaschuk GD. Increased ketone body oxidation provides additional energy for the failing heart without improving cardiac efficiency. Cardiovascular Research. PMID 30778524 DOI: 10.1093/Cvr/Cvz045  0.448
2019 Karwi QG, Zhang L, Wagg CS, Wang W, Ghandi M, Thai D, Yan H, Ussher JR, Oudit GY, Lopaschuk GD. Targeting the glucagon receptor improves cardiac function and enhances insulin sensitivity following a myocardial infarction. Cardiovascular Diabetology. 18: 1. PMID 30626440 DOI: 10.1186/s12933-019-0806-4  0.396
2019 Altamimi TR, Karwi QG, Uddin GM, Fukushima A, Kwong JQ, Molkentin JD, Lopaschuk GD. Cardiac-specific deficiency of the mitochondrial calcium uniporter augments fatty acid oxidation and functional reserve. Journal of Molecular and Cellular Cardiology. 127: 223-231. PMID 30615880 DOI: 10.1016/J.Yjmcc.2018.12.019  0.528
2019 Uddin GM, Pherwani S, Wagg CS, Gopal K, Batran RA, Zhang L, Wu Y, Hussaini N, Rawat S, Ussher JR, Lopaschuk GD. Abstract 868: A Cardiac Specific Branched Chain Aminotransferase Deletion Increases Insulin Stimulated Glucose Oxidation in the Mouse Heart Circulation Research. 125. DOI: 10.1161/res.125.suppl_1.868  0.446
2019 Karwi QG, Wagg CS, Altamimi TR, Lopaschuk GD. Abstract 856: Mitochondrial Protein Kinase B (akt) Translocation Mediates Insulin-stimulated Cardiac Glucose Oxidation Circulation Research. 125. DOI: 10.1161/res.125.suppl_1.856  0.33
2018 Verma S, Rawat S, Ho KL, Wagg CS, Zhang L, Teoh H, Dyck JE, Uddin GM, Oudit GY, Mayoux E, Lehrke M, Marx N, Lopaschuk GD. Empagliflozin Increases Cardiac Energy Production in Diabetes: Novel Translational Insights Into the Heart Failure Benefits of SGLT2 Inhibitors. Jacc. Basic to Translational Science. 3: 575-587. PMID 30456329 DOI: 10.1016/j.jacbts.2018.07.006  0.52
2018 Altamimi TR, Chowdhury B, Singh KK, Zhang L, Mahmood MU, Pan Y, Quan A, Teoh H, Verma S, Lopaschuk GD. A novel role of endothelial autophagy as a regulator of myocardial fatty acid oxidation. The Journal of Thoracic and Cardiovascular Surgery. PMID 30195591 DOI: 10.1016/j.jtcvs.2018.07.047  0.39
2018 Fillmore N, Levasseur JL, Fukushima A, Wagg CS, Wang W, Dyck JRB, Lopaschuk GD. Uncoupling of glycolysis from glucose oxidation accompanies the development of heart failure with preserved ejection fraction. Molecular Medicine (Cambridge, Mass.). 24: 3. PMID 30134787 DOI: 10.1186/s10020-018-0005-x  0.467
2018 Fillmore N, Wagg CS, Zhang L, Fukushima A, Lopaschuk GD. Cardiac Branched-Chain Amino Acid Oxidation is Reduced During Insulin Resistance in the Heart. American Journal of Physiology. Endocrinology and Metabolism. PMID 30106622 DOI: 10.1152/ajpendo.00097.2018  0.493
2018 Karwi QG, Uddin GM, Ho KL, Lopaschuk GD. Loss of Metabolic Flexibility in the Failing Heart. Frontiers in Cardiovascular Medicine. 5: 68. PMID 29928647 DOI: 10.3389/fcvm.2018.00068  0.559
2018 Fukushima A, Zhang L, Huqi A, Lam VH, Rawat S, Altamimi T, Wagg CS, Dhaliwal KK, Hornberger LK, Kantor PF, Rebeyka IM, Lopaschuk GD. Acetylation contributes to hypertrophy-caused maturational delay of cardiac energy metabolism. Jci Insight. 3. PMID 29769443 DOI: 10.1172/jci.insight.99239  0.524
2018 De Jong KA, Barrand S, Wood-Bradley RJ, de Almeida DL, Czeczor JK, Lopaschuk GD, Armitage JA, McGee SL. Maternal high fat diet induces early cardiac hypertrophy and alters cardiac metabolism in Sprague Dawley rat offspring. Nutrition, Metabolism, and Cardiovascular Diseases : Nmcd. PMID 29691147 DOI: 10.1016/j.numecd.2018.02.019  0.392
2018 van Weeghel M, Abdurrachim D, Nederlof R, Argmann CA, Houtkooper RH, Hagen J, Nabben M, Denis S, Ciapaite J, Kolwicz SC, Lopaschuk GD, Auwerx J, Nicolay K, Des Rosiers C, Wanders RJ, et al. Increased cardiac fatty acid oxidation in a mouse model with decreased malonyl-CoA sensitivity of CPT1B. Cardiovascular Research. PMID 29635338 DOI: 10.1093/cvr/cvy089  0.497
2018 Uddin GM, Ho KL, Lopaschuk GD. Treading slowly through hypoxic waters - dichloroacetate to the rescue! The Journal of Physiology. PMID 29451305 DOI: 10.1113/JP275898  0.302
2018 Altamimi TR, Thomas PD, Darwesh AM, Fillmore N, Mahmoud MU, Zhang L, Gupta A, Batran RA, Seubert JM, Lopaschuk G. Cytosolic Carnitine Acetyltransferase as a Source of Cytosolic Acetyl-CoA: A Possible Mechanism for Regulation of Cardiac Energy Metabolism. The Biochemical Journal. PMID 29438065 DOI: 10.1042/BCJ20170823  0.49
2018 Verma S, Rawat S, Ho K, Wagg C, Zhang L, Oudit G, Marx N, Mayoux E, Lopaschuk GD. P1267Empagliflozin prevention of heart failure development in diabetes is associated with an improvement in cardiac energy producition European Heart Journal. 39. DOI: 10.1093/EURHEARTJ/EHY565.P1267  0.316
2018 Moellmann J, Haj-Yehia E, Maxeiner S, Schuett K, Lopaschuk GD, Verma S, Mayoux E, Lehrke M, Marx N. P1266Empagliflozin improves left ventricular diastolic function in db/db mice without altering cardiac expression of enzymes relevant for ketone body or branched chain amino acid catabolism European Heart Journal. 39. DOI: 10.1093/EURHEARTJ/EHY565.P1266  0.322
2018 Ho K, Zhang L, Wagg C, Gopal K, Levasseur J, Leone T, Dyck J, Ussher J, Muoio D, Kelly D, Lopaschuk G. Increasing fatty acid oxidation in the failing heart does not improve cardiac function Journal of Molecular and Cellular Cardiology. 124: 113-114. DOI: 10.1016/J.Yjmcc.2018.07.091  0.593
2018 Karwi QG, Zhang L, Gupta A, Fukushima A, Patel V, Alrob OA, Altamimi T, Wagg CS, Padwal RS, Johnstone DE, Sharma AM, Oudit GY, Lopaschuk GD. Caloric restriction limits fatty acid oxidation and improves cardiac function in heart failure associated with obesity Journal of Molecular and Cellular Cardiology. 124: 99. DOI: 10.1016/J.YJMCC.2018.07.053  0.456
2018 Rawat S, Fukushima A, Zhang L, Huqi A, Lam V, Altamimi T, Wagg C, Petinelli R, Dhaliwal K, Hornberger L, Kantor P, Rebeyka I, Lopaschuk G. Control of cardiac fatty acid metabolism in infants with hypoplastic left heart syndrome Journal of Molecular and Cellular Cardiology. 124: 91-92. DOI: 10.1016/J.Yjmcc.2018.07.032  0.497
2017 Ussher JR, Lopaschuk GD. Decreased Maternal Cardiac Glucose Oxidation: Taking One for the Fetus. Circulation Research. 121: 1299-1301. PMID 29217705 DOI: 10.1161/CIRCRESAHA.117.312098  0.44
2017 De Jong KA, Lopaschuk GD. Complex Energy Metabolic Changes in Heart Failure With Preserved Ejection Fraction and Heart Failure With Reduced Ejection Fraction. The Canadian Journal of Cardiology. PMID 28579160 DOI: 10.1016/j.cjca.2017.03.009  0.552
2017 Rines AK, Chang HC, Wu R, Sato T, Khechaduri A, Kouzu H, Shapiro J, Shang M, Burke MA, Jiang X, Chen C, Rawlings TA, Lopaschuk GD, Schumacker PT, Abel ED, et al. Snf1-related kinase improves cardiac mitochondrial efficiency and decreases mitochondrial uncoupling. Nature Communications. 8: 14095. PMID 28117339 DOI: 10.1038/Ncomms14095  0.437
2017 Ho K, Wagg C, Zhang L, Ussher J, Lopaschuk G. The contribution of fatty acid and ketone body oxidation to energy production increases in the failing heart and is associated with a decrease in cardiac efficiency Journal of Molecular and Cellular Cardiology. 112: 143. DOI: 10.1016/J.Yjmcc.2017.07.041  0.561
2017 Rawat S, Fukushima A, Zhang L, Huqi A, Altamimi T, Wagg C, Hornberger L, Kantor P, Rebeyka I, Lopaschuk G. Cardiac hypertrophy suppresses glucose oxidation in newborns with congenital heart defects Journal of Molecular and Cellular Cardiology. 112: 138. DOI: 10.1016/J.Yjmcc.2017.07.026  0.572
2017 Ahmadi A, Renaud J, Petryk J, Hadizad T, Ruddy T, Dyck J, Beanlands R, deKemp R, Lopaschuk G, Mielniczuk L. INHIBITION OF FATTY ACID OXIDATION IS ASSOCIATED WITH IMPROVED RIGHT VENTRICULAR FUNCTION AND METABOLISM IN TWO RAT MODELS OF PULMONARY ARTERIAL HYPERTENSION Canadian Journal of Cardiology. 33: S167-S168. DOI: 10.1016/J.Cjca.2017.07.326  0.408
2016 Lopaschuk GD. Metabolic Modulators in Heart Disease: Past, Present, and Future. The Canadian Journal of Cardiology. PMID 28279520 DOI: 10.1016/j.cjca.2016.12.013  0.301
2016 Lopaschuk GD. Fatty Acid Oxidation and Its Relation with Insulin Resistance and Associated Disorders. Annals of Nutrition & Metabolism. 68: 15-20. PMID 27931032 DOI: 10.1159/000448357  0.481
2016 Fukushima A, Lopaschuk GD. Acetylation control of cardiac fatty acid β-oxidation and energy metabolism in obesity, diabetes, and heart failure. Biochimica Et Biophysica Acta. PMID 27479696 DOI: 10.1016/j.bbadis.2016.07.020  0.494
2016 Groenendyk J, Lee D, Jung J, Dyck JR, Lopaschuk GD, Agellon LB, Michalak M. Inhibition of the Unfolded Protein Response Mechanism Prevents Cardiac Fibrosis. Plos One. 11: e0159682. PMID 27441395 DOI: 10.1371/Journal.Pone.0159682  0.313
2016 Fukushima A, Alrob OA, Zhang L, Wagg CS, Altamimi T, Rawat S, Rebeyka IM, Kantor PF, Lopaschuk GD. Acetylation and Succinylation Contribute to Maturational Alterations in Energy Metabolism in the Newborn Heart. American Journal of Physiology. Heart and Circulatory Physiology. ajpheart.00900.2015. PMID 27261364 DOI: 10.1152/ajpheart.00900.2015  0.503
2016 Lopaschuk GD. Preface to the BBA special issue "heart lipid metabolism". Biochimica Et Biophysica Acta. PMID 27208401 DOI: 10.1016/j.bbalip.2016.05.007  0.343
2016 Taegtmeyer H, Young ME, Lopaschuk GD, Abel ED, Brunengraber H, Darley-Usmar V, Des Rosiers C, Gerszten R, Glatz JF, Griffin JL, Gropler RJ, Holzhuetter HG, Kizer JR, Lewandowski ED, Malloy CR, et al. Assessing Cardiac Metabolism: A Scientific Statement From the American Heart Association. Circulation Research. 118: 1659-701. PMID 27012580 DOI: 10.1161/Res.0000000000000097  0.336
2016 Fukushima A, Lopaschuk GD. Cardiac fatty acid oxidation in heart failure associated with obesity and diabetes. Biochimica Et Biophysica Acta. PMID 26996746 DOI: 10.1016/j.bbalip.2016.03.020  0.511
2016 Lopatin YM, Rosano GM, Fragasso G, Lopaschuk GD, Seferovic PM, Gowdak LH, Vinereanu D, Hamid MA, Jourdain P, Ponikowski P. Rationale and benefits of trimetazidine by acting on cardiac metabolism in heart failure. International Journal of Cardiology. 203: 909-15. PMID 26618252 DOI: 10.1016/j.ijcard.2015.11.060  0.45
2016 Fukushima A, Huqi A, Zhang L, Lam VH, Altamimi T, Kinugawa S, Tsutsui H, Rebeyka IM, Kantor PF, Lopaschuk GD. Cardiac Hypertrophy in Neonates With Congenital Heart Disease Delays Maturational Alterations in Cardiac Energy Metabolism by Modifying Myocardial Acetylation Control Journal of Cardiac Failure. 22: S230-S231. DOI: 10.1016/J.CARDFAIL.2016.07.413  0.407
2016 Fukushima A, Alrob OA, Zhang L, Wagg CS, Altamimi T, Kinugawa S, Tsutsui H, Rebeyka IM, Kantor PF, Lopaschuk GD. Acetylation Control Contributes to Maturational Alterations in Cardiac Energy Metabolism in the Newborn Heart Journal of Cardiac Failure. 22: S199. DOI: 10.1016/J.CARDFAIL.2016.07.249  0.404
2015 Azam MA, Wagg CS, Massé S, Farid T, Lai PF, Kusha M, Asta J, Jaimes R, Kuzmiak-Glancy S, Kay MW, Lopaschuk GD, Nanthakumar K. Feeding the fibrillating heart: Dichloroacetate improves cardiac contractile dysfunction following VF. American Journal of Physiology. Heart and Circulatory Physiology. 309: H1543-53. PMID 26342067 DOI: 10.1152/Ajpheart.00404.2015  0.523
2015 Patel VB, Mori J, McLean BA, Basu R, Das SK, Ramprasath T, Parajuli N, Penninger JM, Grant MB, Lopaschuk GD, Oudit GY. ACE2 deficiency worsens epicardial adipose tissue inflammation and cardiac dysfunction in response to diet-induced obesity. Diabetes. PMID 26224885 DOI: 10.2337/Db15-0399  0.344
2015 Fukushima A, Milner K, Gupta A, Lopaschuk GD. Myocardial Energy Substrate Metabolism in Heart Failure : from Pathways to Therapeutic Targets. Current Pharmaceutical Design. 21: 3654-64. PMID 26166604  0.575
2015 Masoud WG, Abo Al-Rob O, Yang Y, Lopaschuk GD, Clanachan AS. Tolerance to ischemic injury in remodeled mouse hearts: less ischemic glycogenolysis and preserved metabolic efficiency. Cardiovascular Research. PMID 26150203 DOI: 10.1093/cvr/cvv195  0.357
2015 Sankaralingam S, Lopaschuk GD. Cardiac energy metabolic alterations in pressure overload-induced left and right heart failure (2013 Grover Conference Series). Pulmonary Circulation. 5: 15-28. PMID 25992268 DOI: 10.1086/679608  0.478
2015 Lam VH, Zhang L, Huqi A, Fukushima A, Tanner BA, Onay-Besikci A, Keung W, Kantor PF, Jaswal JS, Rebeyka IM, Lopaschuk GD. Activating PPARα Prevents Post-Ischemic Contractile Dysfunction in Hypertrophied Neonatal Hearts. Circulation Research. 117: 41-51. PMID 25977309 DOI: 10.1161/Circresaha.117.306585  0.76
2015 Mohamed IA, Gadeau AP, Fliegel L, Lopaschuk G, Mlih M, Abdulrahman N, Fillmore N, Mraiche F. Na+/H+ exchanger isoform 1-induced osteopontin expression facilitates cardiomyocyte hypertrophy. Plos One. 10: e0123318. PMID 25884410 DOI: 10.1371/Journal.Pone.0123318  0.317
2015 Gao S, McMillan RP, Zhu Q, Lopaschuk GD, Hulver MW, Butler AA. Therapeutic effects of adropin on glucose tolerance and substrate utilization in diet-induced obese mice with insulin resistance. Molecular Metabolism. 4: 310-24. PMID 25830094 DOI: 10.1016/J.Molmet.2015.01.005  0.332
2015 Fillmore N, Huqi A, Jaswal JS, Mori J, Paulin R, Haromy A, Onay-Besikci A, Ionescu L, Thébaud B, Michelakis E, Lopaschuk GD. Effect of fatty acids on human bone marrow mesenchymal stem cell energy metabolism and survival. Plos One. 10: e0120257. PMID 25768019 DOI: 10.1371/journal.pone.0120257  0.713
2015 Sankaralingam S, Abo Alrob O, Zhang L, Jaswal JS, Wagg CS, Fukushima A, Padwal RS, Johnstone DE, Sharma AM, Lopaschuk GD. Lowering body weight in obese mice with diastolic heart failure improves cardiac insulin sensitivity and function: implications for the obesity paradox. Diabetes. 64: 1643-57. PMID 25524917 DOI: 10.2337/db14-1050  0.35
2015 Wang W, Zhang L, Wagg C, Alrob O, Fillmore N, Wang S, Dyck J, Lopaschuk G. OPTIMIZATION OF CARDIAC ENERGY METABOLISM BY MALONYL COA DECARBOXYLASE INHIBITOR IMPROVES CARDIAC FUNCTION POST MYOCARDIAL INFARCTION IN RATS Canadian Journal of Cardiology. 31: S303. DOI: 10.1016/j.cjca.2015.07.624  0.355
2015 Ahmadi A, Renaud J, Petryk J, Hadizad T, Ruddy T, Dyck J, Beanlands R, deKemp R, Lopaschuk G, Mielniczuk L. FATTY ACID OXIDATION INHIBITION AS A POTENTIAL NOVEL TREATMENT STRATEGY IN PULMONARY ARTERY HYPERTENSION AND RIGHT HEART FAILURE Canadian Journal of Cardiology. 31: S65. DOI: 10.1016/j.cjca.2015.07.150  0.341
2014 Wu R, Chang HC, Khechaduri A, Chawla K, Tran M, Chai X, Wagg C, Ghanefar M, Jiang X, Bayeva M, Gonzalez F, Lopaschuk G, Ardehali H. Cardiac-specific ablation of ARNT leads to lipotoxicity and cardiomyopathy. The Journal of Clinical Investigation. 124: 4795-806. PMID 25329697 DOI: 10.1172/Jci76737  0.506
2014 Fillmore N, Lopaschuk GD. The link between pediatric heart failure and mitochondrial lipids. Journal of Molecular and Cellular Cardiology. 76: 71-2. PMID 25123339 DOI: 10.1016/j.yjmcc.2014.08.002  0.302
2014 Abo Alrob O, Lopaschuk GD. Role of CoA and acetyl-CoA in regulating cardiac fatty acid and glucose oxidation. Biochemical Society Transactions. 42: 1043-51. PMID 25110000 DOI: 10.1042/BST20140094  0.523
2014 Aksentijević D, McAndrew DJ, Karlstädt A, Zervou S, Sebag-Montefiore L, Cross R, Douglas G, Regitz-Zagrosek V, Lopaschuk GD, Neubauer S, Lygate CA. Cardiac dysfunction and peri-weaning mortality in malonyl-coenzyme A decarboxylase (MCD) knockout mice as a consequence of restricting substrate plasticity. Journal of Molecular and Cellular Cardiology. 75: 76-87. PMID 25066696 DOI: 10.1016/J.Yjmcc.2014.07.008  0.756
2014 Ussher JR, Fillmore N, Keung W, Mori J, Beker DL, Wagg CS, Jaswal JS, Lopaschuk GD. Trimetazidine therapy prevents obesity-induced cardiomyopathy in mice. The Canadian Journal of Cardiology. 30: 940-4. PMID 25064584 DOI: 10.1016/j.cjca.2014.04.023  0.331
2014 Ezekowitz JA, Becher H, Belenkie I, Clark AM, Duff HJ, Friedrich MG, Haykowsky MJ, Howlett JG, Kassiri Z, Kaul P, Kim DH, Knudtson ML, Light PE, Lopaschuk GD, McAlister FA, et al. The Alberta Heart Failure Etiology and Analysis Research Team (HEART) study. Bmc Cardiovascular Disorders. 14: 91. PMID 25063541 DOI: 10.1186/1471-2261-14-91  0.31
2014 Alrob OA, Sankaralingam S, Ma C, Wagg CS, Fillmore N, Jaswal JS, Sack MN, Lehner R, Gupta MP, Michelakis ED, Padwal RS, Johnstone DE, Sharma AM, Lopaschuk GD. Obesity-induced lysine acetylation increases cardiac fatty acid oxidation and impairs insulin signalling. Cardiovascular Research. 103: 485-97. PMID 24966184 DOI: 10.1093/cvr/cvu156  0.475
2014 Gao S, McMillan RP, Jacas J, Zhu Q, Li X, Kumar GK, Casals N, Hegardt FG, Robbins PD, Lopaschuk GD, Hulver MW, Butler AA. Regulation of substrate oxidation preferences in muscle by the peptide hormone adropin. Diabetes. 63: 3242-52. PMID 24848071 DOI: 10.2337/Db14-0388  0.349
2014 Heusch G, Libby P, Gersh B, Yellon D, Böhm M, Lopaschuk G, Opie L. Cardiovascular remodelling in coronary artery disease and heart failure. Lancet (London, England). 383: 1933-43. PMID 24831770 DOI: 10.1016/S0140-6736(14)60107-0  0.314
2014 Lee CT, Ussher JR, Mohammad A, Lam A, Lopaschuk GD. 5'-AMP-activated protein kinase increases glucose uptake independent of GLUT4 translocation in cardiac myocytes. Canadian Journal of Physiology and Pharmacology. 92: 307-14. PMID 24708213 DOI: 10.1139/cjpp-2013-0107  0.364
2014 Ussher JR, Keung W, Fillmore N, Koves TR, Mori J, Zhang L, Lopaschuk DG, Ilkayeva OR, Wagg CS, Jaswal JS, Muoio DM, Lopaschuk GD. Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice. The Journal of Pharmacology and Experimental Therapeutics. 349: 487-96. PMID 24700885 DOI: 10.1124/Jpet.114.214197  0.385
2014 Fillmore N, Lopaschuk GD. Malonyl CoA: A promising target for the treatment of cardiac disease. Iubmb Life. PMID 24591219 DOI: 10.1002/iub.1253  0.504
2014 Fillmore N, Mori J, Lopaschuk GD. Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. British Journal of Pharmacology. 171: 2080-90. PMID 24147975 DOI: 10.1111/bph.12475  0.566
2014 Masoud WG, Ussher JR, Wang W, Jaswal JS, Wagg CS, Dyck JR, Lygate CA, Neubauer S, Clanachan AS, Lopaschuk GD. Failing mouse hearts utilize energy inefficiently and benefit from improved coupling of glycolysis and glucose oxidation. Cardiovascular Research. 101: 30-8. PMID 24048945 DOI: 10.1093/cvr/cvt216  0.444
2014 Aksentijevic D, Medway DJ, Sebag-Montefiore L, Zervou S, Douglas G, Lopaschuk GD, Neubauer S, Lygate CA. Metabolic Inflexibility of Malonyl CoA Decarboxylase (MCD) Knockout Mice Leads to Cardiac Remodelling and High Mortality During Peri-Weaning Period Biophysical Journal. 106: 187a. DOI: 10.1016/J.Bpj.2013.11.1054  0.381
2013 Zhang L, Yu X, Cheypesh A, Rebeyka IM, Granoski D, Lopaschuk GD, Li J. Plasma fatty acid levels in children during extracorporeal membrane oxygenation support--a pilot study. The Journal of Extra-Corporeal Technology. 45: 242-7. PMID 24649572  0.318
2013 Mori J, Zhang L, Oudit GY, Lopaschuk GD. Impact of the renin-angiotensin system on cardiac energy metabolism in heart failure. Journal of Molecular and Cellular Cardiology. 63: 98-106. PMID 23886814 DOI: 10.1016/j.yjmcc.2013.07.010  0.379
2013 Zhang L, Jaswal JS, Ussher JR, Sankaralingam S, Wagg C, Zaugg M, Lopaschuk GD. Cardiac insulin-resistance and decreased mitochondrial energy production precede the development of systolic heart failure after pressure-overload hypertrophy. Circulation. Heart Failure. 6: 1039-48. PMID 23861485 DOI: 10.1161/CIRCHEARTFAILURE.112.000228  0.415
2013 Gao S, Casals N, Keung W, Moran TH, Lopaschuk GD. Differential effects of central ghrelin on fatty acid metabolism in hypothalamic ventral medial and arcuate nuclei. Physiology & Behavior. 118: 165-70. PMID 23680429 DOI: 10.1016/J.Physbeh.2013.03.030  0.322
2013 Lee D, Oka T, Hunter B, Robinson A, Papp S, Nakamura K, Srisakuldee W, Nickel BE, Light PE, Dyck JR, Lopaschuk GD, Kardami E, Opas M, Michalak M. Calreticulin induces dilated cardiomyopathy. Plos One. 8: e56387. PMID 23437120 DOI: 10.1371/Journal.Pone.0056387  0.332
2013 Mori J, Alrob OA, Wagg CS, Harris RA, Lopaschuk GD, Oudit GY. ANG II causes insulin resistance and induces cardiac metabolic switch and inefficiency: a critical role of PDK4. American Journal of Physiology. Heart and Circulatory Physiology. 304: H1103-13. PMID 23396452 DOI: 10.1152/Ajpheart.00636.2012  0.371
2013 Gill RS, Lee TF, Manouchehri N, Liu JQ, Lopaschuk G, Bigam DL, Cheung PY. Postresuscitation cyclosporine treatment attenuates myocardial and cardiac mitochondrial injury in newborn piglets with asphyxia-reoxygenation. Critical Care Medicine. 41: 1069-74. PMID 23385100 DOI: 10.1097/Ccm.0B013E3182746704  0.406
2013 Singh KK, Shukla PC, Yanagawa B, Quan A, Lovren F, Pan Y, Wagg CS, Teoh H, Lopaschuk GD, Verma S. Regulating cardiac energy metabolism and bioenergetics by targeting the DNA damage repair protein BRCA1. The Journal of Thoracic and Cardiovascular Surgery. 146: 702-9. PMID 23317938 DOI: 10.1016/J.Cjca.2013.07.344  0.443
2013 Zhabyeyev P, Gandhi M, Mori J, Basu R, Kassiri Z, Clanachan A, Lopaschuk GD, Oudit GY. Pressure-overload-induced heart failure induces a selective reduction in glucose oxidation at physiological afterload. Cardiovascular Research. 97: 676-85. PMID 23257023 DOI: 10.1093/cvr/cvs424  0.39
2013 Piao L, Sidhu VK, Fang YH, Ryan JJ, Parikh KS, Hong Z, Toth PT, Morrow E, Kutty S, Lopaschuk GD, Archer SL. FOXO1-mediated upregulation of pyruvate dehydrogenase kinase-4 (PDK4) decreases glucose oxidation and impairs right ventricular function in pulmonary hypertension: therapeutic benefits of dichloroacetate. Journal of Molecular Medicine (Berlin, Germany). 91: 333-46. PMID 23247844 DOI: 10.1007/S00109-012-0982-0  0.404
2013 Keung W, Ussher JR, Jaswal JS, Raubenheimer M, Lam VH, Wagg CS, Lopaschuk GD. Inhibition of carnitine palmitoyltransferase-1 activity alleviates insulin resistance in diet-induced obese mice. Diabetes. 62: 711-20. PMID 23139350 DOI: 10.2337/db12-0259  0.318
2013 Lewandowski ED, Fischer SK, Fasano M, Banke NH, Walker LA, Huqi A, Wang X, Lopaschuk GD, O'Donnell JM. Acute liver carnitine palmitoyltransferase I overexpression recapitulates reduced palmitate oxidation of cardiac hypertrophy. Circulation Research. 112: 57-65. PMID 22982985 DOI: 10.1161/CIRCRESAHA.112.274456  0.431
2013 Fillmore N, Lopaschuk GD. Targeting mitochondrial oxidative metabolism as an approach to treat heart failure. Biochimica Et Biophysica Acta. 1833: 857-65. PMID 22960640 DOI: 10.1016/j.bbamcr.2012.08.014  0.508
2013 Huqi A, Jaswal J, Perry R, Lam V, Jhangri GS, Rebeyka IM, Lopaschuk GD. Newborns with congenital heart disease and reactive myocardial hypertrophy display altered cardiac energy metabolism and reduced post-surgical functional recovery European Heart Journal. 34: P2140-P2140. DOI: 10.1093/EURHEARTJ/EHT308.P2140  0.415
2013 Huai A, Jaswal J, Lam V, Rebeyka IR, Lopaschuk GD. CARDIAC HYPERTROPHY IN HUMAN NEWBORNS WITH CONGENITAL HEART DISEASE MODIFIES MATURATIONAL CHANGES IN CARDIAC ENERGY METABOLISM AND NEGATIVELY AFFECTS POSTSURGICAL FUNCTIONAL RECOVERY. Journal of the American College of Cardiology. 61: E461. DOI: 10.1016/S0735-1097(13)60461-1  0.381
2012 Ussher JR, Jaswal JS, Lopaschuk GD. Pyridine nucleotide regulation of cardiac intermediary metabolism. Circulation Research. 111: 628-41. PMID 22904042 DOI: 10.1161/CIRCRESAHA.111.246371  0.526
2012 Wu G, Zhang L, Li T, Lopaschuk G, Vance DE, Jacobs RL. Choline Deficiency Attenuates Body Weight Gain and Improves Glucose Tolerance in ob/ob Mice. Journal of Obesity. 2012: 319172. PMID 22778916 DOI: 10.1155/2012/319172  0.348
2012 Mori J, Basu R, McLean BA, Das SK, Zhang L, Patel VB, Wagg CS, Kassiri Z, Lopaschuk GD, Oudit GY. Agonist-induced hypertrophy and diastolic dysfunction are associated with selective reduction in glucose oxidation: a metabolic contribution to heart failure with normal ejection fraction. Circulation. Heart Failure. 5: 493-503. PMID 22705769 DOI: 10.1161/CIRCHEARTFAILURE.112.966705  0.395
2012 Ussher JR, Folmes CD, Keung W, Fillmore N, Jaswal JS, Cadete VJ, Beker DL, Lam VH, Zhang L, Lopaschuk GD. Inhibition of serine palmitoyl transferase I reduces cardiac ceramide levels and increases glycolysis rates following diet-induced insulin resistance. Plos One. 7: e37703. PMID 22629445 DOI: 10.1371/journal.pone.0037703  0.361
2012 Zhang L, Mori J, Wagg C, Lopaschuk GD. Activating cardiac E2F1 induces up-regulation of pyruvate dehydrogenase kinase 4 in mice on a short term of high fat feeding. Febs Letters. 586: 996-1003. PMID 22569253 DOI: 10.1016/j.febslet.2012.02.027  0.317
2012 Ussher JR, Wang W, Gandhi M, Keung W, Samokhvalov V, Oka T, Wagg CS, Jaswal JS, Harris RA, Clanachan AS, Dyck JR, Lopaschuk GD. Stimulation of glucose oxidation protects against acute myocardial infarction and reperfusion injury. Cardiovascular Research. 94: 359-69. PMID 22436846 DOI: 10.1093/Cvr/Cvs129  0.491
2012 Oka T, Lam VH, Zhang L, Keung W, Cadete VJ, Samokhvalov V, Tanner BA, Beker DL, Ussher JR, Huqi A, Jaswal JS, Rebeyka IM, Lopaschuk GD. Cardiac hypertrophy in the newborn delays the maturation of fatty acid β-oxidation and compromises postischemic functional recovery. American Journal of Physiology. Heart and Circulatory Physiology. 302: H1784-94. PMID 22408020 DOI: 10.1152/ajpheart.00804.2011  0.555
2012 Axelsen LN, Keung W, Pedersen HD, Meier E, Riber D, Kjølbye AL, Petersen JS, Proctor SD, Holstein-Rathlou NH, Lopaschuk GD. Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. British Journal of Pharmacology. 165: 2736-48. PMID 22014161 DOI: 10.1111/j.1476-5381.2011.01714.x  0.377
2012 Piao L, Sidhu VK, Fang Y, Thenappan T, Lopaschuk G, Archer S. CHRONIC INHIBITION OF PYRUVATE DEHYDROGENASE KINASE WITH DICHLOROACETATE, IMPROVES CARDIAC METABOLISM AND FUNCTION IN RIGHT VENTRICULAR HYPERTROPHY IN FAWN-HOODED RATS Journal of the American College of Cardiology. 59: E1604. DOI: 10.1016/S0735-1097(12)61605-2  0.413
2012 Azam M, Wagg C, Massé S, Farid T, Lai P, Kusha M, Asta J, Lopaschuk G, Nanthakumar K. 467 Metabolic Modulation for the Management of Cardiac Systolic Dysfunction Following Ventricular Fibrillation Resuscitation Canadian Journal of Cardiology. 28: S271. DOI: 10.1016/j.cjca.2012.07.429  0.318
2011 Nagoshi T, Yoshimura M, Rosano GM, Lopaschuk GD, Mochizuki S. Optimization of cardiac metabolism in heart failure. Current Pharmaceutical Design. 17: 3846-53. PMID 21933140  0.383
2011 Kudej RK, Fasano M, Zhao X, Lopaschuk GD, Fischer SK, Vatner DE, Vatner SF, Lewandowski ED. Second window of preconditioning normalizes palmitate use for oxidation and improves function during low-flow ischaemia. Cardiovascular Research. 92: 394-400. PMID 21835931 DOI: 10.1093/cvr/cvr215  0.38
2011 Lucchinetti E, Wang L, Ko KW, Troxler H, Hersberger M, Zhang L, Omar MA, Lopaschuk GD, Clanachan AS, Zaugg M. Enhanced glucose uptake via GLUT4 fuels recovery from calcium overload after ischaemia-reperfusion injury in sevoflurane- but not propofol-treated hearts. British Journal of Anaesthesia. 106: 792-800. PMID 21474475 DOI: 10.1093/bja/aer065  0.536
2011 Chambers KT, Leone TC, Sambandam N, Kovacs A, Wagg CS, Lopaschuk GD, Finck BN, Kelly DP. Chronic inhibition of pyruvate dehydrogenase in heart triggers an adaptive metabolic response. The Journal of Biological Chemistry. 286: 11155-62. PMID 21321124 DOI: 10.1074/Jbc.M110.217349  0.475
2011 Jaswal JS, Keung W, Wang W, Ussher JR, Lopaschuk GD. Targeting fatty acid and carbohydrate oxidation--a novel therapeutic intervention in the ischemic and failing heart. Biochimica Et Biophysica Acta. 1813: 1333-50. PMID 21256164 DOI: 10.1016/j.bbamcr.2011.01.015  0.592
2011 Rueda-Clausen CF, Morton JS, Lopaschuk GD, Davidge ST. Long-term effects of intrauterine growth restriction on cardiac metabolism and susceptibility to ischaemia/reperfusion. Cardiovascular Research. 90: 285-94. PMID 21097804 DOI: 10.1093/cvr/cvq363  0.314
2011 Keung W, Cadete VJ, Palaniyappan A, Jablonski A, Fischer M, Lopaschuk GD. Intracerebroventricular leptin administration differentially alters cardiac energy metabolism in mice fed a low-fat and high-fat diet. Journal of Cardiovascular Pharmacology. 57: 103-13. PMID 20980918 DOI: 10.1097/FJC.0b013e31820014f9  0.354
2011 Mraiche F, Wagg CS, Lopaschuk GD, Fliegel L. Elevated levels of activated NHE1 protect the myocardium and improve metabolism following ischemia/reperfusion injury. Journal of Molecular and Cellular Cardiology. 50: 157-64. PMID 20974148 DOI: 10.1016/j.yjmcc.2010.10.016  0.468
2011 Zhang L, Ussher JR, Oka T, Cadete VJ, Wagg C, Lopaschuk GD. Cardiac diacylglycerol accumulation in high fat-fed mice is associated with impaired insulin-stimulated glucose oxidation. Cardiovascular Research. 89: 148-56. PMID 20729341 DOI: 10.1093/cvr/cvq266  0.324
2010 Wang L, Ko KW, Lucchinetti E, Zhang L, Troxler H, Hersberger M, Omar MA, Posse de Chaves EI, Lopaschuk GD, Clanachan AS, Zaugg M. Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift. Anesthesiology. 113: 541-51. PMID 20683255 DOI: 10.1097/ALN.0b013e3181e2c1a1  0.46
2010 Kandalam V, Basu R, Abraham T, Wang X, Awad A, Wang W, Lopaschuk GD, Maeda N, Oudit GY, Kassiri Z. Early activation of matrix metalloproteinases underlies the exacerbated systolic and diastolic dysfunction in mice lacking TIMP3 following myocardial infarction. American Journal of Physiology. Heart and Circulatory Physiology. 299: H1012-23. PMID 20675565 DOI: 10.1152/Ajpheart.00246.2010  0.306
2010 Folmes CD, Sawicki G, Cadete VJ, Masson G, Barr AJ, Lopaschuk GD. Novel O-palmitolylated beta-E1 subunit of pyruvate dehydrogenase is phosphorylated during ischemia/reperfusion injury. Proteome Science. 8: 38. PMID 20618950 DOI: 10.1186/1477-5956-8-38  0.449
2010 Lopaschuk GD, Jaswal JS. Energy metabolic phenotype of the cardiomyocyte during development, differentiation, and postnatal maturation. Journal of Cardiovascular Pharmacology. 56: 130-40. PMID 20505524 DOI: 10.1097/FJC.0b013e3181e74a14  0.442
2010 Jessen N, Koh HJ, Folmes CD, Wagg C, Fujii N, Løfgren B, Wolf CM, Berul CI, Hirshman MF, Lopaschuk GD, Goodyear LJ. Ablation of LKB1 in the heart leads to energy deprivation and impaired cardiac function. Biochimica Et Biophysica Acta. 1802: 593-600. PMID 20441792 DOI: 10.1016/j.bbadis.2010.04.008  0.448
2010 Ito M, Jaswal JS, Lam VH, Oka T, Zhang L, Beker DL, Lopaschuk GD, Rebeyka IM. High levels of fatty acids increase contractile function of neonatal rabbit hearts during reperfusion following ischemia. American Journal of Physiology. Heart and Circulatory Physiology. 298: H1426-37. PMID 20154256 DOI: 10.1152/ajpheart.00284.2009  0.497
2010 Carvalho RA, Sousa RP, Cadete VJ, Lopaschuk GD, Palmeira CM, Bjork JA, Wallace KB. Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy. Toxicology. 270: 92-8. PMID 20132857 DOI: 10.1016/J.Tox.2010.01.019  0.519
2010 Lopaschuk GD, Ussher JR, Folmes CD, Jaswal JS, Stanley WC. Myocardial fatty acid metabolism in health and disease. Physiological Reviews. 90: 207-58. PMID 20086077 DOI: 10.1152/physrev.00015.2009  0.467
2010 Piao L, Fang YH, Cadete VJ, Wietholt C, Urboniene D, Toth PT, Marsboom G, Zhang HJ, Haber I, Rehman J, Lopaschuk GD, Archer SL. The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle. Journal of Molecular Medicine (Berlin, Germany). 88: 47-60. PMID 19949938 DOI: 10.1007/S00109-009-0524-6  0.381
2010 Zhang L, Keung W, Samokhvalov V, Wang W, Lopaschuk GD. Role of fatty acid uptake and fatty acid beta-oxidation in mediating insulin resistance in heart and skeletal muscle. Biochimica Et Biophysica Acta. 1801: 1-22. PMID 19782765 DOI: 10.1016/j.bbalip.2009.09.014  0.394
2009 Basu R, Oudit GY, Wang X, Zhang L, Ussher JR, Lopaschuk GD, Kassiri Z. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function. American Journal of Physiology. Heart and Circulatory Physiology. 297: H2096-108. PMID 19801494 DOI: 10.1152/ajpheart.00452.2009  0.392
2009 Ussher JR, Koves TR, Jaswal JS, Zhang L, Ilkayeva O, Dyck JR, Muoio DM, Lopaschuk GD. Insulin-stimulated cardiac glucose oxidation is increased in high-fat diet-induced obese mice lacking malonyl CoA decarboxylase. Diabetes. 58: 1766-75. PMID 19478144 DOI: 10.2337/Db09-0011  0.472
2009 Yan J, Young ME, Cui L, Lopaschuk GD, Liao R, Tian R. Increased glucose uptake and oxidation in mouse hearts prevent high fatty acid oxidation but cause cardiac dysfunction in diet-induced obesity. Circulation. 119: 2818-28. PMID 19451348 DOI: 10.1161/CIRCULATIONAHA.108.832915  0.492
2009 Folmes CD, Wagg CS, Shen M, Clanachan AS, Tian R, Lopaschuk GD. Suppression of 5'-AMP-activated protein kinase activity does not impair recovery of contractile function during reperfusion of ischemic hearts. American Journal of Physiology. Heart and Circulatory Physiology. 297: H313-21. PMID 19429810 DOI: 10.1152/ajpheart.01298.2008  0.547
2009 Folmes CD, Sowah D, Clanachan AS, Lopaschuk GD. High rates of residual fatty acid oxidation during mild ischemia decrease cardiac work and efficiency. Journal of Molecular and Cellular Cardiology. 47: 142-8. PMID 19303418 DOI: 10.1016/j.yjmcc.2009.03.005  0.501
2009 Ussher JR, Lopaschuk GD. Targeting malonyl CoA inhibition of mitochondrial fatty acid uptake as an approach to treat cardiac ischemia/reperfusion. Basic Research in Cardiology. 104: 203-10. PMID 19242641 DOI: 10.1007/s00395-009-0003-9  0.551
2009 Lopaschuk GD. AMP-activated protein kinase control of energy metabolism in the ischemic heart. International Journal of Obesity (2005). S29-35. PMID 18719595 DOI: 10.1038/ijo.2008.120  0.528
2008 Yatscoff MA, Jaswal JS, Grant MR, Greenwood R, Lukat T, Beker DL, Rebeyka IM, Lopaschuk GD. Myocardial hypertrophy and the maturation of fatty acid oxidation in the newborn human heart Pediatric Research. 64: 643-647. PMID 18614968 DOI: 10.1203/PDR.0b013e318184d281  0.475
2008 Fert-Bober J, Sawicki G, Lopaschuk GD, Cheung PY. Proteomic analysis of cardiac metabolic enzymes in asphyxiated newborn piglets. Molecular and Cellular Biochemistry. 318: 13-21. PMID 18607691 DOI: 10.1007/s11010-008-9852-z  0.365
2008 Khairallah RJ, Khairallah M, Gélinas R, Bouchard B, Young ME, Allen BG, Lopaschuk GD, Deschepper CF, Des Rosiers C. Cyclic GMP signaling in cardiomyocytes modulates fatty acid trafficking and prevents triglyceride accumulation. Journal of Molecular and Cellular Cardiology. 45: 230-9. PMID 18590915 DOI: 10.1016/J.Yjmcc.2008.05.012  0.47
2008 Ussher JR, Lopaschuk GD. The malonyl CoA axis as a potential target for treating ischaemic heart disease. Cardiovascular Research. 79: 259-68. PMID 18499682 DOI: 10.1093/cvr/cvn130  0.503
2008 Koves TR, Ussher JR, Noland RC, Slentz D, Mosedale M, Ilkayeva O, Bain J, Stevens R, Dyck JR, Newgard CB, Lopaschuk GD, Muoio DM. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal muscle insulin resistance. Cell Metabolism. 7: 45-56. PMID 18177724 DOI: 10.1016/J.Cmet.2007.10.013  0.32
2008 Zhou L, Huang H, Yuan CL, Keung W, Lopaschuk GD, Stanley WC. Metabolic response to an acute jump in cardiac workload: effects on malonyl-CoA, mechanical efficiency, and fatty acid oxidation. American Journal of Physiology. Heart and Circulatory Physiology. 294: H954-60. PMID 18083904 DOI: 10.1152/Ajpheart.00557.2007  0.494
2008 Wang W, Lopaschuk GD. Metabolic therapy for the treatment of ischemic heart disease: reality and expectations. Expert Review of Cardiovascular Therapy. 5: 1123-34. PMID 18035928 DOI: 10.1586/14779072.5.6.1123  0.51
2008 Taha M, Lopaschuk GD. Alterations in energy metabolism in cardiomyopathies. Annals of Medicine. 39: 594-607. PMID 17934906 DOI: 10.1080/07853890701618305  0.412
2007 Lopaschuk GD, Folmes CD, Stanley WC. Cardiac energy metabolism in obesity. Circulation Research. 101: 335-47. PMID 17702980 DOI: 10.1161/CIRCRESAHA.107.150417  0.339
2007 Carley AN, Atkinson LL, Bonen A, Harper ME, Kunnathu S, Lopaschuk GD, Severson DL. Mechanisms responsible for enhanced fatty acid utilization by perfused hearts from type 2 diabetic db/db mice. Archives of Physiology and Biochemistry. 113: 65-75. PMID 17558605 DOI: 10.1080/13813450701422617  0.409
2007 Onay-Besikci A, Wagg C, Lopaschuk TP, Keung W, Lopaschuk GD. Alpha-lipoic acid increases cardiac glucose oxidation independent of AMP-activated protein kinase in isolated working rat hearts. Basic Research in Cardiology. 102: 436-44. PMID 17530314 DOI: 10.1007/S00395-007-0661-4  0.775
2007 Lam A, Lopaschuk GD. Anti-anginal effects of partial fatty acid oxidation inhibitors. Current Opinion in Pharmacology. 7: 179-85. PMID 17307396 DOI: 10.1016/J.COPH.2006.10.008  0.455
2007 Lopaschuk GD. Optimizing cardiac fatty acid and glucose metabolism as an approach to treating heart failure. Seminars in Cardiothoracic and Vascular Anesthesia. 10: 228-30. PMID 16959756 DOI: 10.1177/1089253206291150  0.447
2006 Lopaschuk GD, Stanley WC. Malonyl-CoA decarboxylase inhibition as a novel approach to treat ischemic heart disease. Cardiovascular Drugs and Therapy / Sponsored by the International Society of Cardiovascular Pharmacotherapy. 20: 433-9. PMID 17136490 DOI: 10.1007/s10557-006-0634-0  0.545
2006 Folmes CD, Lopaschuk GD. Role of malonyl-CoA in heart disease and the hypothalamic control of obesity. Cardiovascular Research. 73: 278-87. PMID 17126822 DOI: 10.1016/J.CARDIORES.2006.10.008  0.408
2006 Dyck JR, Hopkins TA, Bonnet S, Michelakis ED, Young ME, Watanabe M, Kawase Y, Jishage K, Lopaschuk GD. Absence of malonyl coenzyme A decarboxylase in mice increases cardiac glucose oxidation and protects the heart from ischemic injury. Circulation. 114: 1721-8. PMID 17030679 DOI: 10.1161/CIRCULATIONAHA.106.642009  0.573
2006 Cheng JF, Huang Y, Penuliar R, Nishimoto M, Liu L, Arrhenius T, Yang G, O'leary E, Barbosa M, Barr R, Dyck JR, Lopaschuk GD, Nadzan AM. Discovery of potent and orally available malonyl-CoA decarboxylase inhibitors as cardioprotective agents. Journal of Medicinal Chemistry. 49: 4055-8. PMID 16821767 DOI: 10.1021/jm0605029  0.4
2006 Fragasso G, Montano C, Perseghin G, Palloshi A, Calori G, Lattuada G, Oggionni S, Bassanelli G, Locatelli M, Lopaschuk G, Margonato A. The anti-ischemic effect of trimetazidine in patients with postprandial myocardial ischemia is unrelated to meal composition. American Heart Journal. 151. PMID 16781225 DOI: 10.1016/J.Ahj.2006.01.006  0.309
2006 Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acids attenuate insulin regulation of 5'-AMP-activated protein kinase and insulin cardioprotection after ischemia. Circulation Research. 99: 61-8. PMID 16741157 DOI: 10.1161/01.RES.0000229656.05244.11  0.407
2006 Dyck JR, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? The Journal of Physiology. 574: 95-112. PMID 16690706 DOI: 10.1113/jphysiol.2006.109389  0.527
2006 Cheng JF, Mak CC, Huang Y, Penuliar R, Nishimoto M, Zhang L, Chen M, Wallace D, Arrhenius T, Chu D, Yang G, Barbosa M, Barr R, Dyck JR, Lopaschuk GD, et al. Heteroaryl substituted bis-trifluoromethyl carbinols as malonyl-CoA decarboxylase inhibitors. Bioorganic & Medicinal Chemistry Letters. 16: 3484-8. PMID 16644218 DOI: 10.1016/j.bmcl.2006.03.100  0.34
2006 Cheng JF, Chen M, Wallace D, Tith S, Haramura M, Liu B, Mak CC, Arrhenius T, Reily S, Brown S, Thorn V, Harmon C, Barr R, Dyck JR, Lopaschuk GD, et al. Synthesis and structure-activity relationship of small-molecule malonyl coenzyme A decarboxylase inhibitors. Journal of Medicinal Chemistry. 49: 1517-25. PMID 16509570 DOI: 10.1021/jm050109n  0.414
2006 Collier CA, Bruce CR, Smith AC, Lopaschuk G, Dyck DJ. Metformin counters the insulin-induced suppression of fatty acid oxidation and stimulation of triacylglycerol storage in rodent skeletal muscle. American Journal of Physiology. Endocrinology and Metabolism. 291: E182-9. PMID 16478780 DOI: 10.1152/Ajpendo.00272.2005  0.466
2006 DeGrado TR, Kitapci MT, Wang S, Ying J, Lopaschuk GD. Validation of 18F-fluoro-4-thia-palmitate as a PET probe for myocardial fatty acid oxidation: effects of hypoxia and composition of exogenous fatty acids. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 47: 173-81. PMID 16391202  0.407
2006 Sambandam N, Morabito D, Wagg C, Finck BN, Kelly DP, Lopaschuk GD. Chronic activation of PPARalpha is detrimental to cardiac recovery after ischemia. American Journal of Physiology. Heart and Circulatory Physiology. 290: H87-95. PMID 16155108 DOI: 10.1152/Ajpheart.00285.2005  0.459
2005 Stanley WC, Morgan EE, Huang H, McElfresh TA, Sterk JP, Okere IC, Chandler MP, Cheng J, Dyck JR, Lopaschuk GD. Malonyl-CoA decarboxylase inhibition suppresses fatty acid oxidation and reduces lactate production during demand-induced ischemia. American Journal of Physiology. Heart and Circulatory Physiology. 289: H2304-9. PMID 16100246 DOI: 10.1152/Ajpheart.00599.2005  0.477
2005 Stanley WC, Recchia FA, Lopaschuk GD. Myocardial substrate metabolism in the normal and failing heart. Physiological Reviews. 85: 1093-129. PMID 15987803 DOI: 10.1152/physrev.00006.2004  0.483
2005 King KL, Okere IC, Sharma N, Dyck JR, Reszko AE, McElfresh TA, Kerner J, Chandler MP, Lopaschuk GD, Stanley WC. Regulation of cardiac malonyl-CoA content and fatty acid oxidation during increased cardiac power. American Journal of Physiology. Heart and Circulatory Physiology. 289: H1033-7. PMID 15821035 DOI: 10.1152/Ajpheart.00210.2005  0.441
2005 Folmes CD, Clanachan AS, Lopaschuk GD. Fatty acid oxidation inhibitors in the management of chronic complications of atherosclerosis. Current Atherosclerosis Reports. 7: 63-70. PMID 15683605 DOI: 10.1007/S11883-005-0077-2  0.577
2004 Altarejos JY, Taniguchi M, Clanachan AS, Lopaschuk GD. Myocardial ischemia differentially regulates LKB1 and an alternate 5'-AMP-activated protein kinase kinase. The Journal of Biological Chemistry. 280: 183-90. PMID 15507450 DOI: 10.1074/JBC.M411810200  0.365
2004 Leon H, Atkinson LL, Sawicka J, Strynadka K, Lopaschuk GD, Schulz R. Pyruvate prevents cardiac dysfunction and AMP-activated protein kinase activation by hydrogen peroxide in isolated rat hearts. Canadian Journal of Physiology and Pharmacology. 82: 409-16. PMID 15381965 DOI: 10.1139/y04-050  0.389
2004 Onay-Besikci A, Altarejos JY, Lopaschuk GD. gAd-globular head domain of adiponectin increases fatty acid oxidation in newborn rabbit hearts. The Journal of Biological Chemistry. 279: 44320-6. PMID 15269215 DOI: 10.1074/jbc.M400347200  0.769
2004 Dyck JR, Cheng JF, Stanley WC, Barr R, Chandler MP, Brown S, Wallace D, Arrhenius T, Harmon C, Yang G, Nadzan AM, Lopaschuk GD. Malonyl coenzyme a decarboxylase inhibition protects the ischemic heart by inhibiting fatty acid oxidation and stimulating glucose oxidation. Circulation Research. 94: e78-84. PMID 15105298 DOI: 10.1161/01.Res.0000129255.19569.8F  0.596
2004 Lopaschuk GD. Targets for modulation of fatty acid oxidation in the heart. Current Opinion in Investigational Drugs (London, England : 2000). 5: 290-4. PMID 15083595  0.536
2004 Kuang M, Febbraio M, Wagg C, Lopaschuk GD, Dyck JR. Fatty acid translocase/CD36 deficiency does not energetically or functionally compromise hearts before or after ischemia. Circulation. 109: 1550-7. PMID 15023869 DOI: 10.1161/01.CIR.0000121730.41801.12  0.381
2004 Fragasso G, Piatti Md PM, Monti L, Palloshi A, Setola E, Puccetti P, Calori G, Lopaschuk GD, Margonato A. Short- and long-term beneficial effects of trimetazidine in patients with diabetes and ischemic cardiomyopathy. American Heart Journal. 146: E18. PMID 14597947 DOI: 10.1016/S0002-8703(03)00415-0  0.323
2003 Stanley WC, Meadows SR, Kivilo KM, Roth BA, Lopaschuk GD. beta-Hydroxybutyrate inhibits myocardial fatty acid oxidation in vivo independent of changes in malonyl-CoA content. American Journal of Physiology. Heart and Circulatory Physiology. 285: H1626-31. PMID 12969881 DOI: 10.1152/ajpheart.00332.2003  0.37
2003 Lopaschuk GD, Barr R, Thomas PD, Dyck JR. Beneficial effects of trimetazidine in ex vivo working ischemic hearts are due to a stimulation of glucose oxidation secondary to inhibition of long-chain 3-ketoacyl coenzyme a thiolase. Circulation Research. 93: e33-7. PMID 12869392 DOI: 10.1161/01.RES.0000086964.07404.A5  0.496
2003 Sambandam N, Lopaschuk GD. AMP-activated protein kinase (AMPK) control of fatty acid and glucose metabolism in the ischemic heart. Progress in Lipid Research. 42: 238-56. PMID 12689619 DOI: 10.1016/S0163-7827(02)00065-6  0.538
2003 Hopkins TA, Sugden MC, Holness MJ, Kozak R, Dyck JR, Lopaschuk GD. Control of cardiac pyruvate dehydrogenase activity in peroxisome proliferator-activated receptor-alpha transgenic mice. American Journal of Physiology. Heart and Circulatory Physiology. 285: H270-6. PMID 12663261 DOI: 10.1152/ajpheart.00852.2002  0.375
2003 Hopkins TA, Dyck JR, Lopaschuk GD. AMP-activated protein kinase regulation of fatty acid oxidation in the ischaemic heart. Biochemical Society Transactions. 31: 207-12. PMID 12546686 DOI: 10.1042/bst0310207  0.535
2003 Dyck JR, Lopaschuk GD. Malonyl CoA control of fatty acid oxidation in the ischemic heart. Journal of Molecular and Cellular Cardiology. 34: 1099-109. PMID 12392882 DOI: 10.1006/jmcc.2002.2060  0.539
2003 Onay-Besikci A, Campbell FM, Hopkins TA, Dyck JR, Lopaschuk GD, Onay Besikci A. Relative importance of malonyl CoA and carnitine in maturation of fatty acid oxidation in newborn rabbit heart. American Journal of Physiology. Heart and Circulatory Physiology. 284: H283-9. PMID 12388233 DOI: 10.1152/ajpheart.00461.2002  0.75
2002 Osorio JC, Stanley WC, Linke A, Castellari M, Diep QN, Panchal AR, Hintze TH, Lopaschuk GD, Recchia FA. Impaired myocardial fatty acid oxidation and reduced protein expression of retinoid X receptor-alpha in pacing-induced heart failure. Circulation. 106: 606-12. PMID 12147544 DOI: 10.1161/01.CIR.0000023531.22727.C1  0.338
2002 Atkinson LL, Fischer MA, Lopaschuk GD. Leptin activates cardiac fatty acid oxidation independent of changes in the AMP-activated protein kinase-acetyl-CoA carboxylase-malonyl-CoA axis. The Journal of Biological Chemistry. 277: 29424-30. PMID 12058043 DOI: 10.1074/jbc.M203813200  0.57
2002 Sambandam N, Lopaschuk GD, Brownsey RW, Allard MF. Energy metabolism in the hypertrophied heart. Heart Failure Reviews. 7: 161-73. PMID 11988640 DOI: 10.1023/A:1015380609464  0.609
2002 Lopaschuk GD. Metabolic abnormalities in the diabetic heart. Heart Failure Reviews. 7: 149-59. PMID 11988639 DOI: 10.1023/A:1015328625394  0.396
2002 Leong HS, Grist M, Parsons H, Wambolt RB, Lopaschuk GD, Brownsey R, Allard MF. Accelerated rates of glycolysis in the hypertrophied heart: are they a methodological artifact? American Journal of Physiology. Endocrinology and Metabolism. 282: E1039-45. PMID 11934668 DOI: 10.1152/Ajpendo.00507.2001  0.431
2002 Lopaschuk GD. Malonyl CoA control of fatty acid oxidation in the diabetic rat heart. Advances in Experimental Medicine and Biology. 498: 155-65. PMID 11900364 DOI: 10.1007/978-1-4615-1321-6_21  0.483
2002 Liu Q, Docherty JC, Rendell JC, Clanachan AS, Lopaschuk GD. High levels of fatty acids delay the recovery of intracellular pH and cardiac efficiency in post-ischemic hearts by inhibiting glucose oxidation. Journal of the American College of Cardiology. 39: 718-25. PMID 11849874 DOI: 10.1016/S0735-1097(01)01803-4  0.784
2002 Lopaschuk GD, Rebeyka IM, Allard MF. Metabolic modulation: a means to mend a broken heart. Circulation. 105: 140-2. PMID 11790689  0.342
2002 Finck BN, Lehman JJ, Leone TC, Welch MJ, Bennett MJ, Kovacs A, Han X, Gross RW, Kozak R, Lopaschuk GD, Kelly DP. The cardiac phenotype induced by PPARalpha overexpression mimics that caused by diabetes mellitus. The Journal of Clinical Investigation. 109: 121-30. PMID 11781357 DOI: 10.1172/Jci14080  0.494
2002 Recchia FA, Osorio JC, Chandler MP, Xu X, Panchal AR, Lopaschuk GD, Hintze TH, Stanley WC. Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs. American Journal of Physiology. Endocrinology and Metabolism. 282: E197-206. PMID 11739101 DOI: 10.1152/Ajpendo.2002.282.1.E197  0.431
2002 Campbell FM, Kozak R, Wagner A, Altarejos JY, Dyck JR, Belke DD, Severson DL, Kelly DP, Lopaschuk GD. A role for peroxisome proliferator-activated receptor alpha (PPARalpha ) in the control of cardiac malonyl-CoA levels: reduced fatty acid oxidation rates and increased glucose oxidation rates in the hearts of mice lacking PPARalpha are associated with higher concentrations of malonyl-CoA and reduced expression of malonyl-CoA decarboxylase. The Journal of Biological Chemistry. 277: 4098-103. PMID 11734553 DOI: 10.1074/jbc.M106054200  0.562
2001 Longnus SL, Wambolt RB, Barr RL, Lopaschuk GD, Allard MF. Regulation of myocardial fatty acid oxidation by substrate supply. American Journal of Physiology. Heart and Circulatory Physiology. 281: H1561-7. PMID 11557544 DOI: 10.1152/AJPHEART.2001.281.4.H1561  0.431
2001 Taniguchi M, Wilson C, Hunter CA, Pehowich DJ, Clanachan AS, Lopaschuk GD. Dichloroacetate improves cardiac efficiency after ischemia independent of changes in mitochondrial proton leak. American Journal of Physiology. Heart and Circulatory Physiology. 280: H1762-9. PMID 11247790 DOI: 10.1152/AJPHEART.2001.280.4.H1762  0.445
2001 Custalow CB, Watts JA, Thornton L, O'Malley P, Barbee RW, Grattan RM, Lopaschuk GD, Kline JA. Role of fatty acids in the recovery of cardiac function during resuscitation from hemorrhagic shock Shock. 15: 231-238. PMID 11236908 DOI: 10.1097/00024382-200115030-00012  0.518
2001 Barr RL, Lopaschuk GD. Methodology for measuring in vitro/ex vivo cardiac energy metabolism. Journal of Pharmacological and Toxicological Methods. 43: 141-52. PMID 11150742 DOI: 10.1016/S1056-8719(00)00096-4  0.381
2001 Ford WR, Jugdutt BI, Lopaschuk GD, Schulz R, Clanachan AS. Influence of beta-adrenoceptor tone on the cardioprotective efficacy of adenosine A(1) receptor activation in isolated working rat hearts. British Journal of Pharmacology. 131: 537-45. PMID 11015305 DOI: 10.1038/sj.bjp.0703597  0.421
2001 Lopaschuk GD. Alterations in malonyl CoA control of fatty acid oxidation in the ischemic heart Biochemical Society Transactions. 29: A2-A2. DOI: 10.1042/BST029A002  0.487
2001 Salki Y, Panas DL, Lopaschuk GD, Rebeyka IM. Effect of pyruvate in cold cardioplegia on cardiac performance after prolonged ischemia in immature rabbit heart Journal of Molecular and Cellular Cardiology. 33: A177. DOI: 10.1016/S0022-2828(01)90681-9  0.404
2001 Hopkins TA, Dyck JR, Lopaschuk GD. Developmental changes of cardiac glucose metabolism, and pyruvate dehydrogenase activity Journal of Molecular and Cellular Cardiology. 33: A169. DOI: 10.1016/S0022-2828(01)90647-9  0.386
2001 Campbell FM, Kozak R, Wagner A, Altarelos JY, Dyck JR, Belke DD, Severson DL, Weinheimer CJ, Courtois MR, Kelly DP, Lopaschuk GD. PPARα regulates cardiac energy metabolism by controlling malonyl COA concentrations in the heart Journal of Molecular and Cellular Cardiology. 33: A164. DOI: 10.1016/S0022-2828(01)90627-3  0.386
2001 Lopaschuk GD. Improvement of energy metabolism in the ischemic heart Journal of Molecular and Cellular Cardiology. 33: A154. DOI: 10.1016/S0022-2828(01)90594-2  0.368
2001 Dyck JR, Lopaschuk GD. How important is malonyl-CoA decarboxylase as a regulator of fatty acid oxidation in the heart? Journal of Molecular and Cellular Cardiology. 33: A150. DOI: 10.1016/S0022-2828(01)90576-0  0.483
2000 Wambolt RB, Lopaschuk GD, Brownsey RW, Allard MF. Dichloroacetate improves postischemic function of hypertrophied rat hearts. Journal of the American College of Cardiology. 36: 1378-85. PMID 11028498 DOI: 10.1016/S0735-1097(00)00856-1  0.495
2000 Kline JA, Thornton LR, Lopaschuk GD, Barbee RW, Watts JA. Lactate improves cardiac efficiency after hemorrhagic shock Shock. 14: 215-221. PMID 10947169 DOI: 10.1097/00024382-200014020-00023  0.495
2000 Sakamoto J, Barr RL, Kavanagh KM, Lopaschuk GD. Contribution of malonyl-CoA decarboxylase to the high fatty acid oxidation rates seen in the diabetic heart. American Journal of Physiology. Heart and Circulatory Physiology. 278: H1196-204. PMID 10749714 DOI: 10.1152/AJPHEART.2000.278.4.H1196  0.477
2000 Kantor PF, Lucien A, Kozak R, Lopaschuk GD. The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase. Circulation Research. 86: 580-8. PMID 10720420 DOI: 10.1161/01.RES.86.5.580  0.529
2000 Lopaschuk G. Regulation of carbohydrate metabolism in ischemia and reperfusion. American Heart Journal. 139: S115-9. PMID 10650324 DOI: 10.1067/Mhj.2000.103919  0.59
1999 Kline JA, Thornton LR, Lopaschuk GD, Barbee RW, Watts JA. Heart function after severe hemorrhagic shock Shock. 12: 454-461. PMID 10588514 DOI: 10.1097/00024382-199912000-00007  0.376
1999 Belke DD, Larsen TS, Lopaschuk GD, Severson DL. Glucose and fatty acid metabolism in the isolated working mouse heart. The American Journal of Physiology. 277: R1210-7. PMID 10516264 DOI: 10.1152/ajpregu.1999.277.4.R1210  0.582
1999 Fraser H, Lopaschuk GD, Clanachan AS. Alteration of glycogen and glucose metabolism in ischaemic and post-ischaemic working rat hearts by adenosine A1 receptor stimulation. British Journal of Pharmacology. 128: 197-205. PMID 10498852 DOI: 10.1038/sj.bjp.0702765  0.455
1999 Larsen TS, Belke DD, Sas R, Giles WR, Severson DL, Lopaschuk GD, Tyberg JV. The isolated working mouse heart: Methodological considerations Pflugers Archiv European Journal of Physiology. 437: 979-985. PMID 10370078 DOI: 10.1007/S004240050870  0.355
1999 Kantor PF, Robertson MA, Coe JY, Lopaschuk GD. Volume overload hypertrophy of the newborn heart slows the maturation of enzymes involved in the regulation of fatty acid metabolism Journal of the American College of Cardiology. 33: 1724-1734. PMID 10334449 DOI: 10.1016/S0735-1097(99)00063-7  0.475
1999 Dyck JR, Kudo N, Barr AJ, Davies SP, Hardie DG, Lopaschuk GD. Phosphorylation control of cardiac acetyl-CoA carboxylase by cAMP-dependent protein kinase and 5'-AMP activated protein kinase. European Journal of Biochemistry. 262: 184-90. PMID 10231380 DOI: 10.1046/j.1432-1327.1999.00371.x  0.341
1999 Wambolt RB, Henning SL, English DR, Dyachkova Y, Lopaschuk GD, Allard MF. Glucose utilization and glycogen turnover are accelerated in hypertrophied rat hearts during severe low-flow ischemia. Journal of Molecular and Cellular Cardiology. 31: 493-502. PMID 10198181 DOI: 10.1006/JMCC.1998.0804  0.482
1999 Kantor PF, Dyck JR, Lopaschuk GD. Fatty Acid Oxidation in the Reperfused Ischemic Heart The American Journal of the Medical Sciences. 318: 3-14. DOI: 10.1016/S0002-9629(15)40566-X  0.508
1998 Fraser H, Lopaschuk GD, Clanachan AS. Assessment of glycogen turnover in aerobic, ischemic, and reperfused working rat hearts. American Journal of Physiology. Heart and Circulatory Physiology. 275: H1533-H1541. PMID 29592216 DOI: 10.1152/ajpheart.1998.275.5.H1533  0.311
1998 Dyck JRB, Barr AJ, Barr RL, Kolattukudy PE, Lopaschuk GD. Characterization of cardiac malonyl-CoA decarboxylase and its putative role in regulating fatty acid oxidation. American Journal of Physiology. Heart and Circulatory Physiology. 275: H2122-H2129. PMID 29586793 DOI: 10.1152/ajpheart.1998.275.6.H2122  0.512
1998 Liu Q, Clanachan AS, Lopaschuk GD. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts. American Journal of Physiology. Endocrinology and Metabolism. 275: E392-E399. PMID 29585551 DOI: 10.1152/ajpendo.1998.275.3.E392  0.802
1998 Makinde AO, Kantor PF, Lopaschuk GD. Maturation of fatty acid and carbohydrate metabolism in the newborn heart Molecular and Cellular Biochemistry. 188: 49-56. PMID 9823010 DOI: 10.1023/A:1006860104840  0.508
1998 Saiki Y, Lopaschuk GD, Dodge K, Yamaya K, Morgan C, Rebeyka IM. Pyruvate augments mechanical function via activation of the pyruvate dehydrogenase complex in reperfused ischemic immature rabbit hearts. The Journal of Surgical Research. 79: 164-9. PMID 9758733 DOI: 10.1006/JSRE.1998.5397  0.504
1998 Lopaschuk GD. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism. The American Journal of Cardiology. 82: 14K-17K. PMID 9737481 DOI: 10.1016/S0002-9149(98)00532-3  0.531
1998 Liu Q, Clanachan AS, Lopaschuk GD. Acute effects of triiodothyronine on glucose and fatty acid metabolism during reperfusion of ischemic rat hearts. The American Journal of Physiology. 275: E392-9. PMID 9725804 DOI: 10.1152/Ajpendo.1998.275.3.E392  0.799
1998 Ford WR, Lopaschuk GD, Schulz R, Clanachan AS. K(ATP)-channel activation: effects on myocardial recovery from ischaemia and role in the cardioprotective response to adenosine A1-receptor stimulation. British Journal of Pharmacology. 124: 639-46. PMID 9690854 DOI: 10.1038/sj.bjp.0701872  0.431
1998 Belke DD, Wang LC, Lopaschuk GD. Acetyl-CoA carboxylase control of fatty acid oxidation in hearts from hibernating Richardson's ground squirrels. Biochimica Et Biophysica Acta. 1391: 25-36. PMID 9518540 DOI: 10.1016/S0005-2760(97)00199-9  0.553
1997 Gamble J, Lopaschuk GD. Insulin inhibition of 5' adenosine monophosphate-activated protein kinase in the heart results in activation of acetyl coenzyme A carboxylase and inhibition of fatty acid oxidation. Metabolism: Clinical and Experimental. 46: 1270-4. PMID 9361684 DOI: 10.1016/S0026-0495(97)90229-8  0.477
1997 Barr RL, Lopaschuk GD. Direct measurement of energy metabolism in the isolated working rat heart. Journal of Pharmacological and Toxicological Methods. 38: 11-7. PMID 9339411 DOI: 10.1016/S1056-8719(97)86574-4  0.5
1997 Schönekess BO, Allard MF, Henning SL, Wambolt RB, Lopaschuk GD. Contribution of glycogen and exogenous glucose to glucose metabolism during ischemia in the hypertrophied rat heart. Circulation Research. 81: 540-9. PMID 9314835 DOI: 10.1161/01.RES.81.4.540  0.465
1997 Lopaschuk GD. Alterations in fatty acid oxidation during reperfusion of the heart after myocardial ischemia. The American Journal of Cardiology. 80: 11A-16A. PMID 9293951 DOI: 10.1016/S0002-9149(97)00453-0  0.55
1997 Lopaschuk GD. Advantages and limitations of experimental techniques used to measure cardiac energy metabolism. Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology. 4: 316-28. PMID 9278879 DOI: 10.1016/S1071-3581(97)90110-0  0.39
1997 Allard MF, Henning SL, Wambolt RB, Granleese SR, English DR, Lopaschuk GD. Glycogen metabolism in the aerobic hypertrophied rat heart. Circulation. 96: 676-82. PMID 9244242 DOI: 10.1161/01.CIR.96.2.676  0.469
1997 Feuvray D, Lopaschuk GD. Controversies on the sensitivity of the diabetic heart to ischemic injury: the sensitivity of the diabetic heart to ischemic injury is decreased. Cardiovascular Research. 34: 113-20. PMID 9217880 DOI: 10.1016/S0008-6363(97)00037-0  0.308
1997 Stanley WC, Lopaschuk GD, McCormack JG. Regulation of energy substrate metabolism in the diabetic heart. Cardiovascular Research. 34: 25-33. PMID 9217869 DOI: 10.1016/S0008-6363(97)00047-3  0.495
1997 Makinde AO, Gamble J, Lopaschuk GD. Upregulation of 5'-AMP-activated protein kinase is responsible for the increase in myocardial fatty acid oxidation rates following birth in the newborn rabbit. Circulation Research. 80: 482-9. PMID 9118478 DOI: 10.1161/01.RES.80.4.482  0.48
1997 Belke DD, Wang LC, Lopaschuk GD. Effects of hypothermia on energy metabolism in rat and Richardson's ground squirrel hearts. Journal of Applied Physiology (Bethesda, Md. : 1985). 82: 1210-8. PMID 9104858 DOI: 10.1152/JAPPL.1997.82.4.1210  0.444
1997 Schulz R, Dodge KL, Lopaschuk GD, Clanachan AS. Peroxynitrite impairs cardiac contractile function by decreasing cardiac efficiency. The American Journal of Physiology. 272: H1212-9. PMID 9087595 DOI: 10.1152/AJPHEART.1997.272.3.H1212  0.423
1997 Stanley WC, Lopaschuk GD, Hall JL, McCormack JG. Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions. Potential for pharmacological interventions. Cardiovascular Research. 33: 243-57. PMID 9074687 DOI: 10.1016/S0008-6363(96)00245-3  0.512
1997 Lopaschuk GD, Stanley WC. Glucose metabolism in the ischemic heart. Circulation. 95: 313-5. PMID 9008441 DOI: 10.1161/01.CIR.95.2.313  0.441
1997 McCormack JG, Baracos VE, Barr R, Lopaschuk GD. Effects of ranolazine on oxidative substrate preference in epitrochlearis muscle. Journal of Applied Physiology (Bethesda, Md. : 1985). 81: 905-10. PMID 8872662 DOI: 10.1152/JAPPL.1996.81.2.905  0.404
1997 Schönekess BO, Brindley PG, Lopaschuk GD. Calcium regulation of glycolysis, glucose oxidation, and fatty acid oxidation in the aerobic and ischemic heart. Canadian Journal of Physiology and Pharmacology. 73: 1632-40. PMID 8789418 DOI: 10.1139/Y95-725  0.477
1996 Hall JL, Stanley WC, Lopaschuk GD, Wisneski JA, Pizzurro RD, Hamilton CD, McCormack JG. Impaired pyruvate oxidation but normal glucose uptake in diabetic pig heart during dobutamine-induced work. The American Journal of Physiology. 271: H2320-9. PMID 8997289 DOI: 10.1152/AJPHEART.1996.271.6.H2320  0.353
1996 Hall JL, Lopaschuk GD, Barr A, Bringas J, Pizzurro RD, Stanley WC. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels. Cardiovascular Research. 32: 879-85. PMID 8944819 DOI: 10.1016/0008-6363(96)00153-8  0.486
1996 Sidossis LS, Stuart CA, Shulman GI, Lopaschuk GD, Wolfe RR. Glucose plus insulin regulate fat oxidation by controlling the rate of fatty acid entry into the mitochondria. The Journal of Clinical Investigation. 98: 2244-50. PMID 8941640 DOI: 10.1172/Jci119034  0.391
1996 Liu B, Clanachan AS, Schulz R, Lopaschuk GD. Cardiac efficiency is improved after ischemia by altering both the source and fate of protons. Circulation Research. 79: 940-8. PMID 8888686 DOI: 10.1161/01.RES.79.5.940  0.467
1996 Olley PM, Kasserra J, Kozak R, Lopaschuk GD. Synergism between prostaglandin E2 and isoproterenol in stimulating glucose oxidation in the heart. Canadian Journal of Physiology and Pharmacology. 74: 590-7. PMID 8884025 DOI: 10.1139/CJPP-74-5-586  0.459
1996 Itoi T, Lopaschuk GD. Calcium improves mechanical function and carbohydrate metabolism following ischemia in isolated Bi-ventricular working hearts from immature rabbits. Journal of Molecular and Cellular Cardiology. 28: 1501-14. PMID 8841937 DOI: 10.1006/JMCC.1996.0140  0.331
1996 Allard MF, Lopaschuk GD. Ischemia and reperfusion injury in the hypertrophied heart Exs. 76: 423-441. PMID 8805809 DOI: 10.1007/978-3-0348-8988-9_25  0.302
1996 Schönekess BO, Allard MF, Lopaschuk GD. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat hearts. The American Journal of Physiology. 271: H798-805. PMID 8770125 DOI: 10.1152/AJPHEART.1996.271.2.H798  0.526
1996 Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. The American Journal of Physiology. 270: H72-80. PMID 8769736 DOI: 10.1152/AJPHEART.1996.270.1.H72  0.509
1996 Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Inhibition of glycolysis and enhanced mechanical function of working rat hearts as a result of adenosine A1 receptor stimulation during reperfusion following ischaemia. British Journal of Pharmacology. 118: 355-63. PMID 8735638 DOI: 10.1111/j.1476-5381.1996.tb15410.x  0.386
1996 Kudo N, Gillespie JG, Kung L, Witters LA, Schulz R, Clanachan AS, Lopaschuk GD. Characterization of 5'AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemia. Biochimica Et Biophysica Acta. 1301: 67-75. PMID 8652652 DOI: 10.1016/0005-2760(96)00013-6  0.4
1996 McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation. 93: 135-42. PMID 8616920 DOI: 10.1161/01.CIR.93.1.135  0.552
1996 Henning SL, Wambolt RB, Schönekess BO, Lopaschuk GD, Allard MF. Contribution of glycogen to aerobic myocardial glucose utilization. Circulation. 93: 1549-55. PMID 8608624 DOI: 10.1161/01.CIR.93.8.1549  0.415
1996 Schönekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied rat heart function is associated with an increase in cardiac efficiency. European Journal of Pharmacology. 286: 155-66. PMID 8605952 DOI: 10.1016/0014-2999(95)00442-N  0.513
1996 Finegan BA, Lopaschuk GD, Gandhi M, Clanachan AS. Ischemic preconditioning inhibits glycolysis and proton production in isolated working rat hearts. The American Journal of Physiology. 269: H1767-75. PMID 7503276 DOI: 10.1152/AJPHEART.1995.269.5.H1767  0.458
1996 Olley PM, Kasserra J, Kozak R, Lopaschuk GD. Synergism between prostaglandin E2 and isoproterenol in stimulating glucose oxidation in the heart Canadian Journal of Physiology and Pharmacology. 74: 586-589. DOI: 10.1139/y96-053  0.414
1996 Hall JL, Lopaschuk GD, Barr A, Bringas J, Pizzurro RD, Stanley WC. Increased cardiac fatty acid uptake with dobutamine infusion in swine is accompanied by a decrease in malonyl CoA levels Cardiovascular Research. 32: 879-885. DOI: 10.1016/s0008-6363(96)00153-8  0.398
1995 Saddik M, Lopaschuk GD. Triacylglycerol turnover in isolated working hearts of acutely diabetic rats. Canadian Journal of Physiology and Pharmacology. 72: 1110-9. PMID 7882174 DOI: 10.1139/Y94-157  0.483
1995 Lopaschuk GD, Gamble J. The 1993 Merck Frosst Award. Acetyl-CoA carboxylase: an important regulator of fatty acid oxidation in the heart. Canadian Journal of Physiology and Pharmacology. 72: 1101-9. PMID 7882173 DOI: 10.1139/Y94-156  0.507
1995 Kudo N, Barr AJ, Barr RL, Desai S, Lopaschuk GD. High rates of fatty acid oxidation during reperfusion of ischemic hearts are associated with a decrease in malonyl-CoA levels due to an increase in 5'-AMP-activated protein kinase inhibition of acetyl-CoA carboxylase. The Journal of Biological Chemistry. 270: 17513-20. PMID 7615556 DOI: 10.1074/JBC.270.29.17513  0.484
1995 Schönekess BO, Allard MF, Lopaschuk GD. Propionyl L-carnitine improvement of hypertrophied heart function is accompanied by an increase in carbohydrate oxidation. Circulation Research. 77: 726-34. PMID 7554119 DOI: 10.1161/01.RES.77.4.726  0.501
1995 Broderick TL, Quinney HA, Lopaschuk GD. L-carnitine increases glucose metabolism and mechanical function following ischaemia in diabetic rat heart Cardiovascular Research. 29: 373-378. DOI: 10.1016/S0008-6363(96)88594-4  0.348
1995 Broderick TL, Panagakis G, DiDomenico D, Gamble J, Lopaschuk GD, Shug AL, Paulson DJ. L-Carnitine improvement of cardiac function is associated with a stimulation in glucose but not fatty acid metabolism in carnitine-deficient hearts Cardiovascular Research. 30: 815-820. DOI: 10.1016/S0008-6363(95)00111-5  0.491
1994 Gamble J, Lopaschuk GD. Glycolysis and glucose oxidation during reperfusion of ischemic hearts from diabetic rats. Biochimica Et Biophysica Acta. 1225: 191-9. PMID 8280788 DOI: 10.1016/0925-4439(94)90078-7  0.428
1994 Lopaschuk GD, Lakey JR, Barr R, Wambolt R, Thomson AB, Clandinin MT, Rajotte RV. Islet transplantation improves glucose oxidation and mechanical function in diabetic rat hearts. Canadian Journal of Physiology and Pharmacology. 71: 896-903. PMID 8180885 DOI: 10.1139/Y93-136  0.359
1994 Itoi T, Lopaschuk GD. The contribution of glycolysis, glucose oxidation, lactate oxidation, and fatty acid oxidation to ATP production in isolated biventricular working hearts from 2-week-old rabbits. Pediatric Research. 34: 735-41. PMID 8108185 DOI: 10.1203/00006450-199312000-00008  0.531
1994 Allard MF, Schönekess BO, Henning SL, English DR, Lopaschuk GD. Contribution of oxidative metabolism and glycolysis to ATP production in hypertrophied hearts. The American Journal of Physiology. 267: H742-50. PMID 8067430 DOI: 10.1152/AJPHEART.1994.267.2.H742  0.518
1994 Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schönekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochimica Et Biophysica Acta. 1213: 263-76. PMID 8049240 DOI: 10.1016/0005-2760(94)00082-4  0.407
1994 Lopaschuk GD, Collins-Nakai R, Olley PM, Montague TJ, McNeil G, Gayle M, Penkoske P, Finegan BA. Plasma fatty acid levels in infants and adults after myocardial ischemia. American Heart Journal. 128: 61-7. PMID 8017285 DOI: 10.1016/0002-8703(94)90010-8  0.372
1994 Collins-Nakai RL, Noseworthy D, Lopaschuk GD. Epinephrine increases ATP production in hearts by preferentially increasing glucose metabolism. The American Journal of Physiology. 267: H1862-71. PMID 7977816 DOI: 10.1152/AJPHEART.1994.267.5.H1862  0.543
1994 Lopaschuk GD, Witters LA, Itoi T, Barr R, Barr A. Acetyl-CoA carboxylase involvement in the rapid maturation of fatty acid oxidation in the newborn rabbit heart. Journal of Biological Chemistry. 269: 25871-25878. DOI: 10.1016/s0021-9258(18)47327-9  0.488
1993 Broderick TL, Quinney HA, Barker CC, Lopaschuk GD. Beneficial effect of carnitine on mechanical recovery of rat hearts reperfused after a transient period of global ischemia is accompanied by a stimulation of glucose oxidation. Circulation. 87: 972-81. PMID 8443916 DOI: 10.1161/01.CIR.87.3.972  0.563
1993 Finegan BA, Lopaschuk GD, Coulson CS, Clanachan AS. Adenosine alters glucose use during ischemia and reperfusion in isolated rat hearts. Circulation. 87: 900-8. PMID 8443910 DOI: 10.1161/01.CIR.87.3.900  0.43
1993 Itoi T, Huang L, Lopaschuk GD. Glucose use in neonatal rabbit hearts reperfused after global ischemia. The American Journal of Physiology. 265: H427-33. PMID 8368344 DOI: 10.1152/AJPHEART.1993.265.2.H427  0.504
1993 Schulz R, Strynadka KD, Panas DL, Olley PM, Lopaschuk GD. Analysis of myocardial plasmalogen and diacyl phospholipids and their arachidonic acid content using high-performance liquid chromatography. Analytical Biochemistry. 213: 140-6. PMID 8238866 DOI: 10.1006/ABIO.1993.1397  0.324
1993 Lopaschuk GD, Spafford MA. Differences in myocardial ischemic tolerance between 1- and 7-day-old rabbits. Canadian Journal of Physiology and Pharmacology. 70: 1315-23. PMID 1490250 DOI: 10.1139/Y92-184  0.471
1993 Lopaschuk GD, Saddik M. The relative contribution of glucose and fatty acids to ATP production in hearts reperfused following ischemia. Molecular and Cellular Biochemistry. 116: 111-6. PMID 1480139 DOI: 10.1007/BF01270577  0.591
1993 Lopaschuk GD, Saddik M, Barr R, Huang L, Barker CC, Muzyka RA. Effects of high levels of fatty acids on functional recovery of ischemic hearts from diabetic rats. The American Journal of Physiology. 263: E1046-53. PMID 1476176 DOI: 10.1152/ajpendo.2006.263.6.E1046  0.372
1993 Lopaschuk GD, Collins-Nakai RL, Itoi T. Developmental changes in energy substrate use by the heart. Cardiovascular Research. 26: 1172-80. PMID 1288863 DOI: 10.1093/CVR/26.12.1172  0.434
1992 Davies NJ, McVeigh JJ, Lopaschuk GD. Effects of TA-3090, a new calcium channel blocker, on myocardial substrate utilization in ischemic and nonischemic isolated working fatty acid-perfused rat hearts. Circulation Research. 68: 807-17. PMID 1742868 DOI: 10.1161/01.RES.68.3.807  0.468
1992 Davies NJ, Lovlin RE, Lopaschuk GD. Effect of exogenous fatty acids on reperfusion arrhythmias in isolated working perfused hearts. The American Journal of Physiology. 262: H1796-801. PMID 1621838 DOI: 10.1152/AJPHEART.1992.262.6.H1796  0.495
1992 Finegan BA, Clanachan AS, Coulson CS, Lopaschuk GD. Adenosine modification of energy substrate use in isolated hearts perfused with fatty acids. The American Journal of Physiology. 262: H1501-7. PMID 1590454 DOI: 10.1152/AJPHEART.1992.262.5.H1501  0.513
1992 Davies NJ, Schulz R, Olley PM, Strynadka KD, Panas DL, Lopaschuk GD. Lysoplasmenylethanolamine accumulation in ischemic/reperfused isolated fatty acid-perfused hearts. Circulation Research. 70: 1161-8. PMID 1576737 DOI: 10.1161/01.RES.70.6.1161  0.494
1992 Broderick TL, Barr RL, Quinney HA, Lopaschuk GD. Acute insulin withdrawal from diabetic BB rats decreases myocardial glycolysis during low-flow ischemia. Metabolism: Clinical and Experimental. 41: 332-8. PMID 1542273 DOI: 10.1016/0026-0495(92)90280-N  0.322
1992 Saddik M, Lopaschuk G. Myocardial triglyceride turnover during reperfusion of isolated rat hearts subjected to a transient period of global ischemia. Journal of Biological Chemistry. 267: 3825-3831. DOI: 10.1016/s0021-9258(19)50600-7  0.316
1992 Broderick T, Quinney H, Lopaschuk G. Carnitine stimulation of glucose oxidation in the fatty acid perfused isolated working rat heart. Journal of Biological Chemistry. 267: 3758-3763. DOI: 10.1016/s0021-9258(19)50590-7  0.488
1991 Nicholl TA, Lopaschuk GD, McNeill JH. Effects of free fatty acids and dichloroacetate on isolated working diabetic rat heart. The American Journal of Physiology. 261: H1053-9. PMID 1928388 DOI: 10.1152/AJPHEART.1991.261.4.H1053  0.392
1991 Lopaschuk GD, Russell JC. Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat Journal of Applied Physiology. 71: 1302-1308. PMID 1757353 DOI: 10.1152/JAPPL.1991.71.4.1302  0.308
1991 Lopaschuk GD, Spafford MA, Marsh DR. Glycolysis is predominant source of myocardial ATP production immediately after birth American Journal of Physiology - Heart and Circulatory Physiology. 261. PMID 1750528 DOI: 10.1152/AJPHEART.1991.261.6.H1698  0.437
1991 Saddik M, Lopaschuk G. Myocardial triglyceride turnover and contribution to energy substrate utilization in isolated working rat hearts Journal of Biological Chemistry. 266: 8162-8170. DOI: 10.1016/s0021-9258(18)92956-x  0.337
1990 Lopaschuk GD, Spafford MA. Energy substrate utilization by isolated working hearts from newborn rabbits. The American Journal of Physiology. 258: H1274-80. PMID 2337162 DOI: 10.1152/AJPHEART.1990.258.5.H1274  0.465
1990 Lopaschuk GD, Spafford MA, Davies NJ, Wall SR. Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia Circulation Research. 66: 546-553. PMID 2297817 DOI: 10.1161/01.RES.66.2.546  0.51
1990 McVeigh JJ, Lopaschuk GD. Dichloroacetate stimulation of glucose oxidation improves recovery of ischemic rat hearts. The American Journal of Physiology. 259: H1079-85. PMID 2221115 DOI: 10.1152/AJPHEART.1990.259.4.H1079  0.55
1990 Lopaschuk GD, Spafford MA. Acute insulin withdrawal contributes to ischemic heart failure in spontaneously diabetic BB Wistar rats. Canadian Journal of Physiology and Pharmacology. 68: 462-6. PMID 2182188 DOI: 10.1139/Y90-065  0.386
1990 LOPASCHUK G. Differential effects of fatty acids on reperfusion recovery of ischemic hearts from control and diabetic rats Journal of Molecular and Cellular Cardiology. 22: S42. DOI: 10.1016/0022-2828(90)91434-9  0.344
1989 Wall SR, Lopaschuk GD. Glucose oxidation rates in fatty acid-perfused isolated working hearts from diabetic rats Biochimica Et Biophysica Acta (Bba)/Lipids and Lipid Metabolism. 1006: 97-103. PMID 2804076 DOI: 10.1016/0005-2760(89)90328-7  0.49
1989 Lopaschuk GD, McNeil GF, McVeigh JJ. Glucose oxidation is stimulated in reperfused ischemic hearts with the carnitine palmitoyltransferase 1 inhibitor, Etomoxir. Molecular and Cellular Biochemistry. 88: 175-9. PMID 2779537 DOI: 10.1007/BF00223440  0.502
1989 Lopaschuk GD, Spafford M. Response of isolated working hearts to fatty acids and carnitine palmitoyltransferase I inhibition during reduction of coronary flow in acutely and chronically diabetic rats. Circulation Research. 65: 378-87. PMID 2526694 DOI: 10.1161/01.RES.65.2.378  0.396
1988 Lopaschuk GD, Wall SR, Olley PM, Davies NJ. Etomoxir, a carnitine palmitoyltransferase I inhibitor, protects hearts from fatty acid-induced ischemic injury independent of changes in long chain acylcarnitine Circulation Research. 63: 1036-1043. PMID 3197271 DOI: 10.1161/01.RES.63.6.1036  0.446
1988 Lopaschuk GD. Insulin effects on pantothenic acid uptake in isolated perfused working hearts from diabetic rats. Diabetes. 37: 1335-9. PMID 3046966 DOI: 10.2337/diab.37.10.1335  0.375
1987 Lopaschuk GD, Neely JR. Stimulation of myocardial coenzyme A degradation by fatty acids. The American Journal of Physiology. 253: H41-6. PMID 3605370 DOI: 10.1152/AJPHEART.1987.253.1.H41  0.379
1987 Lopaschuk GD, Neely JR. Coenzyme A degradation in the heart: effects of diabetes and insulin. Journal of Molecular and Cellular Cardiology. 19: 281-8. PMID 3298661 DOI: 10.1016/S0022-2828(87)80595-3  0.362
1987 LOPASCHUK G, TSANG H. Fatty acid metabolism in isolated working hearts from spontaneously diabetic “BB”wistar rats* Journal of Molecular and Cellular Cardiology. 19: S54-S54. DOI: 10.1016/S0022-2828(87)80169-4  0.353
1987 Lopaschuk G, Michalak M, Tsang H. Regulation of pantothenic acid transport in the heart. Involvement of a Na+-cotransport system. Journal of Biological Chemistry. 262: 3615-3619. DOI: 10.1016/s0021-9258(18)61397-3  0.301
1986 Lopaschuk GD, Hansen CA, Neely JR. Fatty acid metabolism in hearts containing elevated levels of CoA. The American Journal of Physiology. 250: H351-9. PMID 3953832 DOI: 10.1152/AJPHEART.1986.250.3.H351  0.437
1984 LOPASCHUK G, BERKICH D, NEELY J. Stimulation of myocardial CoA degradation by fatty acids* Journal of Molecular and Cellular Cardiology. 16: 47-47. DOI: 10.1016/S0022-2828(84)80498-8  0.314
Show low-probability matches.